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Abstract
This work describes a computer model of the immune system’s response to infection,
speciﬁcally the cytotoxic T lymphocyte (CTL) response. CTLs play an important role in
the control of infectious agents, and they are essential components of our defense against
HIV, cancer, and other diseases of great public interest. Immunologists are interested in
manipulating and enhancing the CTL response to these diseases, whether by vaccination
or drug therapy, but the process can be difﬁcult and ad hoc. A combination of animal
experimentation, limited human testing, and simple mathematical models have been the
primary sources of guidance in the efforts to address these diseases.
Computer models provide an alternative strategy for exploring immune system ther-
apies. Recently developed laboratory techniques that have revealed and quantiﬁed many
aspects of CTL behavior provide an unprecedented opportunity to develop detailed mod-
els. The model used in this work integrates many of these new ﬁndings into a coherent
system that simulates an immune response to viral infection. This model reproduces many
of the phenomena seen in CTL responses but not captured by other mathematical or com-
puter models and can be used to explore vaccination strategies.
viThe value of modeling goes beyond simply making predictions. It allows one to per-
form experiments difﬁcult, or even impossible, to perform in the laboratory. For example,
in a computer model one can replicate experiments exactly or choose to allow stochastic
ﬂuctuations to inﬂuence the outcome. In biological systems, achieving this level of control
is impossible. Model-building can also be used as a vehicle for hypothesis testing by for-
mulating one’s assumptions about a system’s behavior as a model. If the model’s behavior
does not match real-world experimental results, the initial assumptions can be changed
and a new model built. The model presented here is the result of a series of such choices.
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Introduction §
My father always said if you translate a proverb from one language into an-
other, you pass for a poet. The same for science. Work strictly within one area,
and it’s diminishing returns, hard to make progress. But translate a concept
from its ﬁeld for use where it is unknown, and it is always fresh and powerful.
In buying outside, you are doing intellectual arbitrage. The rate limiting step
inthisisyourwillingnesstocontinuouslytranslate, toforcestrangelanguages
to be yours, to live in between, to be everywhere and nowhere.
—Luca Turin, as quoted in The Emperor of Scent by Chandler Burr
It is easy for us to take our immune systems for granted. They usually rid our bod-
ies of infectious agents quietly and reliably. The immune system only calls attention to
itself when these pathogens are not effectively controlled and illness strikes. High-proﬁle
epidemics, such as AIDS and hepatitis C, have forced the public to learn more about im-
munity, and technical jargon like “viral load” and “T cell count” are entering common
usage.
T cells play a major role in our body’s defense against these viruses. In particular, one
kind of T cell, the cytotoxic T lymphocyte (CTL), mounts attacks against cells infected
with viruses and other intracellular pathogens. However, the CTL response is sometimes
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deﬁcient (as in the case of AIDS) or even harmful (which can result in autoimmune disor-
ders such as diabetes and arthritis). Studying CTLs will advance our understanding of the
pathology of these diseases and give us insight into potential treatment strategies.
Our knowledge of T cells is advancing rapidly. Less than 50 years ago, immunologists
used coarse surgical methods to gather the ﬁrst evidence of the existence and function of
T cells (Miller, 1961; Claman et al., 1966). In the past decade, new technologies, such
as CFSE labeling (Lyons and Parish, 1994), MHC tetramers (Altman et al., 1996), and
two-photon imaging (Miller et al., 2002), have given scientists the unprecedented ability
to observe T cells in vivo. I summarize current understanding of CTLs in the ﬁrst half of
Chapter 2. Despite the wealth of data now available, we are still struggling to understand
how CTLs behave during an immune response. More sophisticated methods are needed to
organize and integrate this information.
This work documents my attempt to understand and model the CTL response to infec-
tion. Modeling provides a framework in which to express the relationships among things
in the world. By necessity, we simplify the real world to simulate the phenomena that
interest us. Thus, the process of model formulation involves not only deciding which data
are correct, but also selecting which are essential to replicate the phenomena of interest
and which are not. Once a model is developed, it can be used to perform experiments that
would be too difﬁcult or even impossible to perform on the “real” system.
Immunological modeling is a relatively new ﬁeld, and the second half of Chapter 2
describes the models most closely related to mine. The choice of modeling approach in-
ﬂuences the kinds of knowledge one can incorporate and the results that can be produced.
Most immunological models are mathematical—systems of equations that can be solved.
Mathematical models are usually extremely simple in order to be tractable. Simplicity
can make their results more robust and general, but it can also force the scientist to omit
essential properties of the system. For example, much of the immunological data gained
using the latest laboratory techniques is difﬁcult to incorporate into these models. I have
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constructed a computer model to study CTLs. Computer models can be a great deal more
complex than mathematical models, and can therefore include more of these recent ﬁnd-
ings. A handful of other computer models have been used in immunology, but none have
focused on CTL responses.
I deﬁne the behavior of CTLs and viruses in my model in Chapter 3. In this model,
viruses infect healthy cells, and infected cells produce more virus. CTLs respond to the
infection by reproducing rapidly and eliminating infected cells. The model integrates the
ﬁndings from dozens of laboratory experiments into a single coherent description of CTL
responses. Adding detail to CTL behavior in a model can be computationally expensive,
but I use a stage-structured modeling approach that efﬁciently represents the actions of
hundreds of billions of immune cells. With this model, one can begin to make predictions
about how CTLs will behave in different circumstances. The immunological data used to
construct the model are subject to interpretation, and several alternative assumptions are
brieﬂy listed in Appendix B.
Chapter 4 describes the rules the model uses to determine the strength of interactions
between CTLs and antigens in the model. Most cells present a sample of their internal
proteins on their surfaces, and CTLs have receptors to sense these proteins. This mecha-
nism allows CTLs to detect if a cell contains abnormal proteins, such as those produced
by viruses and intracellular bacteria. An individual CTL’s receptors are speciﬁc to a small
subset of proteins, and the body creates millions of different CTLs so it can detect a wide
variety. The strength of the bond between a CTL’s receptors and an infected cell’s sur-
face proteins determines how quickly the CTL can eliminate the infected cell. Accurate
molecular simulations of the binding process are too complex to embed in a larger model
of T cell behavior, so I use a simpler, abstract representation of this interaction. I am not
as concerned with the mechanics of CTL–antigen interactions as with the fact that these
interactions can have a range of strengths. Including a spectrum of CTLs with different
binding characteristics allows the model to produce a greater variety of immunological
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phenomena. A typical CTL response to antigen is composed of CTLs that have various
afﬁnities to the antigen, and the composition of the response can affect the ability of the
immune system to eliminate the infection.
In Chapter 5, I use the model to provide possible explanations for phenomena observed
in the laboratory and to make predictions that could be veriﬁed by experimentalists. I ex-
plored two facets of CTL behavior: detection and response. Before the immune system
can resolve an infection, it must ﬁrst be able to detect it. Detection is difﬁcult because
CTLs must distinguish between uninfected cells and those harboring viruses. The model
includes a simpliﬁed representation of the process that the immune system uses to create
a set of CTLs that is both accurate and efﬁcient at making this distinction, and I used the
model to quantify the efﬁciency of this process. After the pathogen is detected, CTLs can
eliminate infected cells. I describe several experiments to demonstrate that the model’s
results agree with well-characterized CTL behavior, indicating that the model’s represen-
tation of the CTL response is plausible.
The basic CTL model deﬁned in Chapter 3 replicates responses in which the immune
response clears an infection quickly. In situations in which it does not (e.g., chronic dis-
eases such as AIDS), the model assumptions are not valid. The dynamics of prolonged
immune responses are not well-characterized, so in Chapter 6 I extend the model based
on one of many competing theories. A common feature of prolonged infections is the pre-
mature reduction of the CTL response, known as immune exhaustion. I test the effects of
adding exhaustion, as well as the CTL response to a mutating pathogen.
Finally, I make a few concluding remarks in Chapter 7.
I have made efforts to make this work accessible to readers unfamiliar with immunol-
ogy or computer science. Chapter 2 summarizes the immunology necessary to understand
the model, and I have included a short glossary of immunological terms (which starts on
page 122). For the readers who are familiar with T cell biology, I have compared my
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results to those from laboratory experiments and have proposed additional experiments
that could be performed to validate my results. At the ends of Chapters 3–6 are short
summaries to make this work easier for all audiences to follow.
Enjoy.
5Chapter 2
Background and related work §
Scientists often have a naive faith that if only they could discover enough
facts about a problem, these facts would somehow arrange themselves in a
compelling and true solution.
—Theodosius Dobzhansky, Mankind Evolving
A good physicist is a man with original ideas. A good engineer is a person
who makes a design that works with as few original ideas as possible.
—Freeman Dyson, Adventures in Experimental Physics
This chapter summarizes the biological and modeling background that informs my
own work. Section 2.1 outlines the T cell biology necessary to understand my model.
Because other immune cell types are not explicitly represented in my model, their inter-
actions with T cells will be only brieﬂy outlined. Section 2.2 reviews related models of
the adaptive immune system. These models can be roughly grouped into mathematical
and computer models. My model borrows a few techniques from prior computer models,
but for efﬁciency, I use a stochastic stage-structured approach to modeling. This technique
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Figure 2.1: A simpliﬁed T cell life cycle. Immature T cells are subjected to thymic se-
lection, and those that survive become na¨ ıve cells. Na¨ ıve cells, when exposed to antigen,
become effector cells, which rapidly proliferate and eliminate infected cells in a primary
response. At the end of the response, long-lived memory cells remain. When exposed to
the same antigen, these memory cells participate in a secondary response in which they
replicate and eliminate infected cells. Some of these secondary effectors then revert to
memory cells.
allows the model to represent billions of discrete cells in a few thousand bytes of computer
memory.
2.1 T cell biology
Cytotoxic T cells (CTLs) are essential for the control of viral infections. The life cycle of
CTLs is summarized in Figure 2.1. Na¨ ıve T cells, or cells that have not yet been exposed
to antigen, circulate through the body looking for antigen presenting cells (APCs) that
express indications that the body is infected by virus. Once they receive stimulation from
APCs and from another class of T cells known as helper T cells, CTLs begin their response
to the infection. These stimulated CTLs, known as effector cells, circulate throughout the
body to eliminate cells that are infected by the virus. It is their unique ability to distinguish
between infected and uninfected cells that allows them to eliminate cells that harbor virus.
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2.1.1 T cell receptors and repertoire
T cells have the unique ability to non-invasively view a cell’s contents, allowing them
to detect intra-cellular pathogens, because most cells present portions of their internal
proteins on their cell surfaces. Presentation takes place when a cell processes a sample
of its internal proteins into short peptide fragments that form complexes with cell surface
proteins called major histocompatibility (MHC) class I molecules. There are hundreds of
MHC class I alleles in humans (Marsh et al., 2002), and an individual can express as many
as six of them. Each MHC type binds a particular set of peptides and is thus capable of
presenting a different set of peptides than other MHCs. When a CTL binds to peptide–
MHC complexes, it can initiate a series of actions that leads to the destruction of the
infected cell.
One of the primary factors that determines whether a T cell binds to a cell is the afﬁnity
of its T cell receptor (TCR) for the peptide–MHC complexes. Each T cell expresses thou-
sands of copies of identical receptors that bind to their cognate peptide–MHC complexes
with high afﬁnity. Thus, both the target cell peptides and the particular MHC type that
presents the peptide play a role in determining afﬁnity. The set of all TCR speciﬁcities in a
body, on the order of 107 in humans (Arstila et al., 1999) and 106 in mice (Pannetier et al.,
1993), comprise the T cell repertoire. Avidity, or the sum of the binding interactions be-
tween the receptors of a CTL and the surface of a target cell, determines whether a CTL
recognizes the target. The number of copies of a particular peptide displayed by a target
cell (its expression density) affects the avidity of the interaction. Due to thymic selection,
described below, it is unlikely that a T cell will react to an uninfected cell—infected cells
express foreign (e.g., virally encoded) peptides that make them subject to T cell responses.
The antigenic peptides that stimulate T cells are known as epitopes.
T cell receptors are generated with seemingly random speciﬁcities, so many potentially
harmful self-reactive ones are created. Most are screened out early in their maturation
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process in the thymus, where they are exposed to a large array of the body’s own peptides
presented on MHC molecules. During positive selection, T cells that have an extremely
weak avidity to self peptides bound to MHC are eliminated (Blackman et al., 1990). It
is believed that this process eliminates T cells that have such poor avidity to MHC that
they would not bind to any peptide–MHC pairs. Negative selection eliminates those that
bind too tightly to MHC–self peptides (Kappler et al., 1987), ensuring that potentially
self-reactive T cells are eliminated. This process might create “holes” in the repertoire
that would allow antigenic epitopes that are sufﬁciently similar to self peptides to escape
immune system detection. About 1–3% of pre-selection T cells pass both these “tests” and
leave the thymus to join the peripheral repertoire as na¨ ıve T cells (Shortman et al., 1990).
2.1.2 T cell response
A na¨ ıve T cell remains quiescent until it receives antigenic stimulation from its cog-
nate peptide–MHC complex. Larger antigen doses stimulate a greater fraction of
na¨ ıve cells (perhaps by recruiting more low-afﬁnity T cells) but probably do not af-
fect the degree to which the individual cells are stimulated (Kaech and Ahmed, 2001).
In other words, stimulation of individual cells might be “all or nothing.” After stim-
ulation, na¨ ıve cells appear to be committed to a programmed response that causes
them to divide and acquire effector functions even in the absence of continuing anti-
genic stimulation (Kaech and Ahmed, 2001; van Stipdonk et al., 2001). For the ﬁrst 24
hours, they do not replicate (Oehen and Brduscha-Riem, 1998; Gett and Hodgkin, 2000;
Veiga-Fernandes et al., 2000; van Stipdonk et al., 2001), but after this initial phase, they
can rapidly undergo a ﬁxed number of divisions (up to 8 or more) (Kaech and Ahmed,
2001) once every 5 to 8 hours (Murali-Krishna et al., 1998; Gett and Hodgkin, 2000;
van Stipdonk et al., 2001). After a few divisions, they acquire effector functions, such
as cytotoxicity (Opferman et al., 1999; Auphan-Anezin et al., 2003). Effector CTLs kill
target cells either by releasing perforins that create holes in the target cell’s membrane
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or by triggering apoptosis (i.e., cell suicide) in the target cell. Even during this period
of rapid expansion, the cells have a high death rate, reducing net population growth. Af-
ter initial expansion, the death rate dominates CTL kinetics and the population declines
rapidly (Badovinac et al., 2002).
Effector cells can become impaired by over-stimulation by antigen. High doses or
repetitive stimulation can cause activation-induced cell death in T cells (Shi et al., 1989;
Hildeman et al., 2002). The death of over-stimulated cells causes the overall CTL re-
sponse to diminish or disappear within a few days, a phenomenon known as exhaus-
tion (Moskophidis et al., 1993). Chronic infection has been found to cause a progressive
lossoffunction in effectorCTL,starting with the inability toproduce certain cytokinesand
ending in T cell death (Fuller and Zajac, 2003; Wherry et al., 2003). The memory cells
created in the presence of antigen might also be impaired (Wherry et al., 2002), which in-
dicates that the impairment could be an intrinsic property of the cell that does not change
when antigen is removed.
2.1.3 T cell memory
After the activation and proliferation in response to an infection, most of the T
cells activated in the response die, but a small subpopulation persists as memory
cells (Murali-Krishna et al., 1999). Memory cells are able to mount a quicker and
more aggressive response in future encounters with the same or closely related patho-
gens (Dutton et al., 1998). This secondary response can clear an infection before sig-
niﬁcant damage is inﬂicted upon the body. Immunological memory forms the basis of
vaccination, in which an organism is exposed to viral antigens in order to build immune
memory to the virus.
All effector T cells involved in a response to antigen appear to have the same prob-
ability of converting to memory cells cells (Sourdive et al., 1998; Busch et al., 1998a;
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Blattman et al., 2000). The clonal composition of responding effectors in a primary in-
fection is thus “mirrored” in the resulting memory population. However, this repertoire
can be altered in the secondary response to antigen (Bousso et al., 2000). Some mem-
ory cell clones are preferentially recruited into the secondary response, resulting in their
increased representation in memory.
It takes 2 or 3 weeks for a CTL to turn into a memory cell after the initial infec-
tion (Kaech et al., 2002). Therefore, memory cells are not likely to join the immune re-
sponse that initially generated them. CTLs can die or form defective memory cells in the
presence of persistent infection (Masopust et al., 2004). Therefore, if the immune sys-
tem can not eliminate antigen quickly, the formation of immunological memory can be
impaired.
Upon antigenic stimulation, memory cells begin to proliferate almost immediately
and develop cytotoxicity within a few hours (Bachmann et al., 1999; Barber et al., 2003;
Byers et al., 2003). They probably have the same sensitivity to antigen as na¨ ıve
cells (Bachmann et al., 1999; Kersh et al., 2003), although some studies found their stim-
ulation requirements to be lower (Pihlgren et al., 1996). Their replication rates are ap-
proximately the same as recently activated na¨ ıve cells. Memory cell-derived effectors
die at a slower rate than effectors created in the primary response (Veiga-Fernandes et al.,
2000; Grayson et al., 2002), giving them a faster accumulation rate and possibly allowing
a larger portion of them to revert to memory. Presumably the shorter time to acquire ef-
fector functions, the larger starting populations, and their faster accumulation rates allow
memory cells to clear infected cells much faster than na¨ ıve cells.
Homeostatic mechanisms appear to regulate the size of the memory pool, which re-
mains approximately constant in size throughout an organism’s lifetime (Rocha et al.,
1989). New memory cells from heterologous infections appear to displace the memory
cells from responses to prior infections (Selin et al., 1996; McNally et al., 2001). In the
absence of immune system challenges, memory cells turn over slowly (Tough and Sprent,
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1994; Dutton et al., 1998; Murali-Krishna et al., 1999).
2.1.4 Lymphocytic choriomeningitis virus: A model pathogen
Much of what we know about CTL responses in vivo comes from studies of lympho-
cytic choriomeningitis virus (LCMV) infections in mice (Armstrong and Lillie, 1934;
Traub, 1935). LCMV stimulates a well-characterized CTL-mediated immune response,
and infection is generally asymptomatic and eliminated quickly by the immune re-
sponse (Lehmann-Grube, 1988). However, high doses of certain LCMV strains can cause
chronic infection, resulting in immune exhaustion (Moskophidis et al., 1993). Because its
major epitopes have been identiﬁed, the responses of cells speciﬁc to each epitope can be
studied (Butz and Bevan, 1998). It is assumed that the CTL response in humans is anal-
ogous to that seen in this animal model. Using LCMV in inbred mouse lines as a model
system allows researchers to observe CTL behavior in greater detail than would be pos-
sible in humans. The computer model described in Chapters 3 and 4 is calibrated using
mouse data for this reason, but the model can be recalibrated using human data when it
becomes available.
2.2 Related work
Most immunological models can be classiﬁed into two categories: differential equation
models and agent-based models. Differential equation models have a long history of suc-
cess in immunology and other ﬁelds, but they have many shortcomings, listed in Sec-
tion 2.2.1. Agent-based modeling is a relatively new approach, and its strengths comple-
ment mathematical models. Only a handful of agent-based models of the adaptive immune
system exist, and representatives are described in Section 2.2.2. Agent-based modeling is
computationally expensive, especially if one wants to simulate billions of immune cells,
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so I chose to use an efﬁcient stochastic stage-structured approach to modeling, outlined in
Section 2.2.3.
2.2.1 Differential equation models
Differential equation models have long been used for immune system and viral infection
modeling (Bell, 1970; Dibrov et al., 1977; Pˇ rikrylov´ a et al., 1992; Perelson and Weisbuch,
1992; Ho et al., 1995; Nowak and Bangham, 1996; Bocharov, 1998; Perelson, 2002). In
most of these models, populations of antigens and immune cells are represented as contin-
uous variables, and systems of ordinary differential equations (ODEs) deﬁne their behav-
iors over time. Analytical techniques allow modelers to deﬁne regimes of system behavior
and their associated parameters and initial conditions. For example, one can determine
the model parameters for which an infection is effectively cleared by the immune sys-
tem (Bocharov, 1998). The solutions capture the average behavior of large populations
of perfectly mixed, identical individuals. Many techniques that could make these mod-
els more faithful to biological reality, such as adding time delays or age-structured partial
differential equations (Antia et al., 2003), complicate solving the models analytically or
numerically.
There are many simple differential equation models of the T cell response to antigen,
several of which are reviewed in Nowak and May (2000) and Perelson (2002). These
models are generally single-purpose models, by which I mean that they are purpose-built
to match a small set of experimental data. Two differential equation T cell models are
particularly closely related to my work. One, by Bocharov, ﬁts a large set of T cell and
virus data gathered from mice challenged with LCMV (Bocharov, 1998). The second,
by Antia et al., is a model of the antigen-independent, or programmed, T cell response to
antigen (Antia et al., 2003).
Bocharov (1998) describes an ODE model of the murine CTL response to LCMV.
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In this model, there are 3 main variables: a virus population, a precursor CTL popula-
tion (including both na¨ ıve and memory cells), and a non-replicating effector CTL popula-
tion. The presence of virus induces precursor CTLs to proliferate and convert to effector
CTLs, which clear virus. The effector population declines due to their lytic interactions
with virus, activation-induced cell death (AICD) from exposure to high viral loads, and
their own limited life span. The model was calibrated using experimental data from low-,
moderate-, and high-dose infections of LCMV-D in C57BL/6 mice. A later version of the
model included compartments representing different organs in a mouse (Bocharov et al.,
2003).
As with most differential equation models, these models are stateless. In other words,
the system has no memory and its behavior is determined solely by its current state. How-
ever, some immunological phenomena require the use of state, and these can be captured
in these models by using delay differential equations. For example, it is assumed that
prolonged high levels of antigen induce anergy in T cells. Therefore, the attrition due
to anergy in the precursor T cell population is the product of the current population, the
current viral load, and the viral load at time t −t, where t is the current time and t is a
constant. Thus, precursor T cell levels will decline when exposed to virus over time inter-
val t, but not when the interval is less than t. Although the mathematical representation of
this term is simple, the assumptions that it entails are not. Because the term depends only
on the viral load at two time points, the viral load before or between these points has no
effect. The “real-world” interpretation of delay differential terms is not obvious.
To my knowledge, the models described in Antia et al. (2003) are the ﬁrst to include
the programmed response of T cells. This inclusion is signiﬁcant because it allows T
cells to have state. Without state, T cell growth would be strictly antigen-dependent, only
proliferating in the presence of antigen. The addition of state allows T cells to continue
proliferating when the antigen load diminishes. In effect, the T cell response has “momen-
tum,” which makes it robust to ﬂuctuations in antigen load. Antia et al. (2003) describes
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two implementations of the same model, one as a partial differential equation and one as a
set of ordinary differential equations. The results of the two are qualitatively similar. The
models are at an early stage of development. In their discussion, the authors enumerate
many extensions to their model that would make it more realistic. Many of these exten-
sions are already implemented in my model, including a simple cell cycle model based on
Smith and Martin (1973), explicit processes for cell division and death rather than a single
net population growth process, and a one-day time lag before a cell’s ﬁrst division.
2.2.2 Agent-based models
Agent-based simulation is a promising technique made feasible with the advent of greater
computer power. These simulations monitor the actions of a large number of simple enti-
ties, or agents, in order to observe their aggregate behavior. Each agent consists of state
variables and a set of rules that governs its behavior, and agents can interact either di-
rectly with each other or indirectly through the environment. Because all individuals in a
population are explicitly represented, they can have unique histories and behaviors. The
combined behavior of these agents is observed in a simulation.
Agent-based modeling has many features suited to modeling the immune response. It
is adept at incorporating stochastic events, which appear to be crucial in regulating im-
mune function (Germain, 2001). A single chance event, such as the serendipitous recog-
nition of a cancer antigen by a single cell in the immune system, can determine the fate
of an organism (Ochsenbein et al., 2001). The addition of randomness to a model allows
one to explore the distribution of possible outcomes, as in Detours and Perelson (2000),
as opposed to only the single most likely one addressed by most mathematical models.
This is especially valuable when studying immune responses, as even genetically identi-
cal individuals can exhibit different responses to the same antigen (Lin and Welsh, 1998;
Bousso et al., 1998). Because small numbers of cells are involved in the beginning of an
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immune response (Ehl et al., 1998; Bousso et al., 1999), using a discrete model might be
moresuitableinthiscontextthanacontinuousone. Theexistingagent-basedmodelsofthe
adaptive immune system, such as IMMSIM (Celada and Seiden, 1992; Seiden and Celada,
1992; Kleinstein and Seiden, 2000), the B cell model of Smith et al. (Smith et al., 1999),
and the self-nonself discrimination model of Langman and Cohn (Cohn et al., 2002;
Langman et al., 2003), take advantage of these features. Another advantage of agent-based
models is that by explicitly representing individual cells, they are in many ways closer to
the modeled system. In contrast to population-level models, agent-based model param-
eters correspond to actual properties of the cells, and the output of these models can be
processed so that they can be observed at any level, from the level of the individual cell to
the whole organism.
An early immunological model described in Farmer et al. (1986) represents idiotypic
network (Jerne, 1974) interactions among B cells. The authors outline the similarities be-
tween idiotypic networks and the classiﬁer systems of Holland (Holland, 1986). The work
introduces the use of binary strings to represent epitopes and receptors. A string match
rule determines whether a receptor binds to an epitope based on the distance between their
associated strings. If their strings are complementary, or nearly complementary, the re-
ceptor binds the epitope. Many other immunological models, including mine (Chapter 4),
have adopted similar string representations of epitopes and receptors.
The most mature agent-based model of the immune system is probably IMM-
SIM (Celada and Seiden, 1992; Seiden and Celada, 1992). It is described as a “general-
ized” or “hyper” cellular automata model of the immune system, but within the individual
“sites” it behaves like a typical spatially implicit agent-based system. Each site is popu-
lated with various kinds of entities, such as T cells, B cells, antigens, and antibodies. At
each time step, each has a chance either to perform an action. These actions include in-
teracting stochastically with other occupants of the same site and migrating to other sites.
Thus, each site behaves like a well-mixed portion of an organism’s immune system. Each
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entity is associated with a bit-string, representing its receptors (if it is an immune cell)
or epitopes (if it is an antigen). The likelihood of interactions is determined by a string
match rule that quantiﬁes the similarity between a receptor and an epitope. The IMMSIM
group has published several papers that propose explanations for immunological observa-
tions (Morpurgo et al., 1995; Stewart et al., 1997; Kohler et al., 2000).
My model addresses only a subset of the immunological phenomena that IMMSIM
does. While IMMSIM simulates a system with antigen presenting cells, B cells, helper T
cells, and cytotoxic T cells, my model only attempts to capture the dynamics of cytotoxic
T cells. I also choose not to include spatial effects because there is insufﬁcient laboratory
data to calibrate the distribution and movements of T cells throughout an organism. The
smaller scope of my model allows the simulation to be run much more quickly, and thus
more often, so the distribution of thousands of outcomes can be studied. Even more im-
portantly, by limiting my model to CTL response, it can be more easily calibrated with
empirical data. Many of the components of IMMSIM can not be accurately calibrated
because the model includes such a large variety of cells and their interactions. There are
many behaviors that are not yet quantiﬁed in biological systems, so IMMSIM must use ar-
bitrary values. Although one can use models such as IMMSIM to make estimates of these
unknown quantities (e.g., by running parameters sweeps and Monte Carlo simulations),
the task becomes infeasible when there are too many unknown parameters.
While qualitative models might expose novel mechanisms that can explain certain phe-
nomena, I believe that more useful predictions can be made by carefully calibrating the
model with real-world data. For example, my model uses a realistic-sized T cell repertoire,
while IMMSIM simulates an artiﬁcially small repertoire. Qualitative models give little in-
dication of the frequency or magnitude of events. Quantitative modeling is essential in
studying the immune system. Small differences in the quantity of a pathogen exposed to
the immune system can mean the difference between immune system tolerance and a vig-
orous immune response. Slight changes in growth rates can greatly affect the outcome of
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an immune response, as previous immune system simulations have postulated that there is
a “race” between a rapidly reproducing pathogen and the immune response (Smith et al.,
1999; Kohler et al., 2000). Seemingly minor and improbable events can trigger a cascade
with signiﬁcant consequences (Germain, 2001).
Derek Smith implemented a spatially implicit B cell model for studying in-
ﬂuenza (Smith et al., 1999). In his model, all B cell receptors and antigenic epitopes are
represented by strings. Binding afﬁnity is determined by the Hamming distance (deﬁned
in Section A.1) between receptor and epitope strings. A high afﬁnity match will cause
a B cell to replicate with a high mutation rate (somatic hypermutation). These B cells
release antibodies, which neutralize the antigen. An important contribution of Smith’s
work is the use of “lazy evaluation” to allow the model to accommodate a realistic-sized
repertoire (Smith et al., 1998). The principle of lazy evaluation is to perform only the
computations that are needed by the ﬁnal result. Smith noted that the only B cells that
are recruited into a response are those that bind sufﬁciently well to the antigen, and
the remaining B cells are quiescent. In the model, these quiescent cells do not need
to be instantiated. Therefore, rather than create a simulation with all 107 −108 B cell
clones with distinct receptors, one only needs to include the 102 −103 that could actu-
ally respond to the antigen. The receptors of these responding cells are generated by
creating random strings uniformly distributed close to the epitope. In the past, mod-
elers would either need substantial computing resources to simulate a realistic number
of cells (Detours and Perelson, 2000; Bernaschi and Castiglione, 2001) or use artiﬁcially
small repertoires (Kleinstein and Seiden, 2000).
I adapted Smith’s lazy evaluation technique to create only the CTLs that can respond
to the antigens in the simulation. CTLs, unlike B cells, are subject to thymic selection and
bind to MHC in addition to the antigen. These issues are solved by the models of Detours,
described below. I take an additional step to reduce the computational cost of immunolog-
ical simulation. Although the lazy evaluation technique reduces the number of clones, it
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does not greatly reduce the number of cells involved in the response. Although the number
of clones responding to an antigen is small, the number of cells is not. A handful of clones
can generate millions of responding T cells. To make his simulation manageable, Smith
makes each “agent” in his simulation represent 10 cells (Smith, 1997). Because the T cell
response can be initiated by 25–50 cells (Ehl et al., 1998), a granularity of 10 cells might
be too coarse—it could be important to allow cells to respond individually, not as groups.
Section 2.2.3 describes the stage-structured modeling technique that allows me to achieve
this ﬁne granularity efﬁciently.
In contrast to Smith’s dynamic model of B cell responses, Vincent Detours’ model
investigates the static properties of the na¨ ıve T cell repertoire without including response
to antigen (Detours et al., 1999). This model uses strings to represent both the antigenic
peptides and the portion of the MHC molecules that come into contact with the TCR.
These two strings are concatenated then compared to the strings representing the TCRs
to determine their afﬁnity. Detours greatly increased the computational efﬁciency of his
model by extending Smith’s lazy generation technique to take thymic selection into ac-
count (Detours et al., 2001). In Smith’s original algorithm, it was assumed that B cell
receptor strings are distributed randomly across the universe of strings. Including thymic
selection would violate this assumption in two ways. The ﬁrst is that T cell receptors
must bind to MHC as well as peptide, so TCRs have a non-random afﬁnity to MHC. The
second is that the T cell receptors must also have an intermediate afﬁnity to self pep-
tides because of positive and negative selection. Thus, the T cell receptors that respond
to an epitope are not uniformly distributed—they are inﬂuenced by both the MHC and
self peptide strings. Detours’ complex algorithm takes these effects into account and can
efﬁciently generate a TCR repertoire for a particular MHC–peptide string. His implemen-
tation is speciﬁc to his “xor” string matching rule (deﬁned in Section A.2), in which the
afﬁnity between two strings is the sum of the bitwise xor of their digits. The parameters
of the model are calibrated using real-world data (Detours et al., 2000) in order to allow
for the quantitative exploration of certain T cell repertoire properties, such as alloreactiv-
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ity (Detours and Perelson, 1999, 2000).
I have implemented his efﬁcient T cell repertoire generation algorithm and generalized
his algorithm to two other string matching rules: Hamming and Manhattan (described
in Appendix A). For the alternative match rules, I use an algorithm that is less efﬁcient
but also less complex than Detours’ original xor implementation. My implementation is
described in Section 4.2.
The disadvantage of using other match rules is that the parameters used by the
Detours et al. (2001) algorithm must be modiﬁed. The parameters are not easy to com-
pute, and it is difﬁcult to validate them except by comparing a variety of average statistics
of the outputs from lazy and eager versions of the model. There is the danger that the lazy
repertoire differs from the fully evaluated one in important but subtle ways that are not de-
tected by the chosen statistical measures. Therefore, I have decided to choose a simpler but
less computationally efﬁcient approach. Because the pre-selection TCR repertoire is ran-
dom and uniform over the universe of TCRs, it can be generated lazily in exactly the same
manner as the B cell repertoire in Smith’s work. The distances between each TCR from
the pre-selection repertoire and all of the MHC–self peptide complexes can be computed
to determine which cells survive to join the na¨ ıve repertoire. This approach can generate
up to 100 times more TCRs than will actually join the na¨ ıve pool, but it is conceptually
simpler than Detours’ scheme and is thus less subject to error.
2.2.3 Stochastic stage-structured modeling
For computational efﬁciency, I use a stochastic stage-structured approach to modeling
the cytotoxic T cell population (Chao et al., 2003). Stage-structured models have been
used to model populations in ecology (Lefkovitch, 1965; Usher, 1966; Manly, 1990) but
have rarely been applied to immune systems (e.g., Kleinstein and Singh (2001)). In stage-
structured models, an individual’s or cell’s life cycle is divided into stages, such as devel-
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opmental maturity or differentiation states. All individuals in a given stage are assumed
to be identical. The transition probabilities between stages are speciﬁed, and at each time
step, these probabilities are used to determine how many of the individuals in each stage
transition to another stage. Stochasticity can be added to the model if needed, and the num-
ber of individuals that transition between two stages in a time step can be determined by
drawing from a random distribution. Analytical techniques have been developed for study-
ing these models, but when there are interacting populations (e.g., T cells and antigens),
it is often easier to simply run the model on a computer multiple times and observe the
distribution of outcomes. My modeling approach is described in more detail in Chapter 3.
By using discrete rather than continuous population variables and by explicitly spec-
ifying the actions and transitions of cells as probabilities per individual cell, my model
enforces the realistic behavior of individual cells without the computational cost of rep-
resenting each cell explicitly. The model attempts to strike a balance between the un-
realistically small number of populations used by the analytical approaches described in
Section 2.2.1 and and the unwieldy one-agent-per-cell implementations of the agent-based
modelsdescribedinSection2.2.2. BecauseIdonotintendtosolvemysystemanalytically,
the model can accommodate multiple cell states. However, to make the model more efﬁ-
cient than an equivalent agent-based model, the number of possible cell states is reduced
to a manageable number (described in section 3.2.4).
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The model §
Science is what we understand well enough to explain to a computer. Art is
everything else we do.
—Donald Knuth, from the Foreword to A=B by Marko Petkovsek,
Herbert Wilf, and Doron Zeilberger
When I model I pretty much go blank. You can’t think too much or it doesn’t
work.
—Paulina Porizkova
In this chapter, I describe my model of CTL response to infection. The model has two
main subcomponents. One is a difference equation virus infection model (Section 3.1).
In this model, virus infects healthy target cells, and the infected cells produce more virus.
The other component is a stochastic stage-structured T cell life cycle model (Section 3.2).
After T cells in the model are ﬁrst stimulated by infected cells, they progress through a
series of stages of differentiation, in which they proliferate, eliminate infected cells, then
convert to memory cells. Including the T cell life cycle results in a more realistic portrayal
of the dynamics of an immune response.
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Figure 3.1: The virus infection model in the absence of an immune response. Virus (V)
infects target cells (T), which become infected cells (I). Infected cells produce virus. A
constant source replenishes the target cell population.
3.1 Virus dynamics
I adopt a standard model of viral infection previously used to describe human immunodeﬁ-
ciencyvirus(HIV)andhepatitisCvirus(HCV)dynamics(Wei et al.,1995;Perelson et al.,
1996; Neumann et al., 1998). In the absence of an immune response, the course of a viral
infection is described by the following:
˙ T = l−dTT −bTV, (3.1)
˙ I = bTV −dII, (3.2)
˙ V = pI−cV (3.3)
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where T is the number of uninfected (or “target”) cells, I is the number of infected cells,
V is the number of virus particles, l is the rate of uninfected cell production, p is the rate
of virus production by infected cells, b is the infectivity parameter, dT is the death rate for
target cells, dI is the death rate for infected cells, and c is the clearance rate for free virus.
The system is represented schematically in Figure 3.1. Typically, after infection the viral
load and the number of infected cells increase exponentially, peak, and then decline.
In my implementation, I use a difference equation version of the system of ODEs
described by equations 3.1-3.3:
DT = (l−dTT −bTV)Dt, (3.4)
DI = (bTV −dII)Dt, (3.5)
DV = (pI−cV)Dt (3.6)
where Dt =10 minutes. In order to include stochasticity, the terms in equations 3.4-3.6 are
randomly drawn from the appropriate distributions at each time step, an approach similar
to that taken in Kleinstein and Singh (2001). I assume that the variables are constant over
the short interval Dt and are updated at the end of each time step. I also randomly permute
the order in which the different infectious agents are updated using a Fisher-Yates shuf-
ﬂe (Fisher and Yates, 1938). The shufﬂing should eliminate any bias caused by the order
in which these agents are updated. In Salﬁ (1974), the author notes that not all possible
permutations can be created using such algorithms unless the random seed is extremely
large. I believe that this potential problem does not noticeably affect the behavior of my
model’s implementation. For the production of uninfected cells and the virus production
rate, I assume that they are governed by Poisson processes, and I draw from the Poisson
distribution with their expected values as the mean (i.e., lDt and pIDt, respectively).
To stochastically determine the number of cells out of a population of identical cells
that perform a certain action, such as dying, I draw randomly from the binomial distri-
bution. In order to do this, I must convert continuous rates into probabilities that events
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occur during a time step. If a process occurs at rate r, then the probability that it ﬁrst oc-
curs at time t is deﬁned by the exponential distribution E (r) = re−rt. The probability that
it occurs at or before time t is 1−e−rt. Thus, rates r can be converted to probabilities that
the processes occur in a time step Dt, 1−e−rDt. If there are n cells each with a probability
p of performing an action, then drawing from the binomial B(n,p) is a computationally
efﬁcient way to determine the number of cells that perform the action. For example, I
compute the number of uninfected cells T that are infected in each time step by converting
their infection rate, bV, to the probability that they will become infected in a time step,
1−e−bVDt, and randomly drawing a value from B(T,1−e−bVDt).
To validate my implementation of the infection dynamics difference equation model,
I compared its results to an alternate version using Gillespie’s Direct Method (Gillespie,
1977), which is an exact stochastic simulation technique that explicitly generates all dis-
crete events rather than computing how many reactions occur in a given time step. Gille-
spie developed two algorithms for exact stochastic simulation of chemical reactions, the
Direct Method and the First Reaction Method. Gibson and Bruck (2000) contains a good
explanation of both. I use the Direct Method because it is more computationally efﬁcient.
To convert the virus infection model to a Direct Method simulation, the difference
equations are expressed as a set of parallel reactions:
l → T +1,I,V (3.7)
T
dT → T −1,I,V (3.8)
TV
b
→ T −1,I+1,V (3.9)
I
dI → T,I−1,V (3.10)
I
p → T,I,V +1 (3.11)
V
c → T,I,V −1 (3.12)
Each of these reactions represents the conversion of reactants (terms on the left of the
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arrow) to products (terms on the right). The products are written in terms of how a reaction
affects each of the three state variables T, I, and V. For example, T −1 indicates that the
number of target cells is decremented by 1, V +1 indicates that the number of virus are
incremented by 1, and I indicates that the number of infected cells is not affected by
the reaction. Reactions occur at rates proportional to the product of the quantities of the
inputs times the reaction rate constant, which is written over the arrow of each reaction.
For example, reaction 3.9 proceeds at rate bTV, and each “reaction event” eliminates one
target cell T and produces one infected cell I while the virus level V remains constant.
Reaction 3.7 does not depend on the presence of any inputs, so its rate is l and it increases
the number of target cells T by one.
The Direct Method simulation is initialized by setting the target cell, infected cell,
and virus levels to the desired levels and setting the time elapsed to 0. One advances the
state of the simulation by choosing one of the six reactions to occur, changing the state
of the system according to the reaction chosen, and incrementing elapsed simulation time.
For each iteration, a reaction is chosen randomly with probabilities proportional to their
reaction rates. Thus, the fastest reaction is most likely to be selected, but the slowest
reaction can be chosen. Note that these reaction rates are not constant—most of them
depend on the current numbers of target cells, infected cells, and virus—so they need to
be computed each time before a reaction is chosen. Once a reaction is chosen, the state
of the system (i.e., T, I, and V) is updated to reﬂect the effects of the chosen reaction.
The simulation time must then be advanced. One would expect that the time increment
would depend on the speed of the reaction chosen, but it does not. The time increment is
simply drawn randomly from an exponential distribution with the sum of all six reaction
rates as its parameter: E (l+dTT +bTV +dII+pI+cV). This time is added to the total
time elapsed. At this point, the effects on the system of performing one reaction have been
computed. Subsequent reactions can be chosen in the same manner, typically until the
simulation time reaches the desired value.
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Figure 3.2: Comparison of the average outputs from the difference equation model and
the Gillespie Direct method version. The averages (solid, dashed, and dot-dash lines)
and standard deviations (indicated by the ﬁne dotted lines) of 100 runs of the difference
equation model and the averages from the Gillespie version (symbols with no lines) are
plotted. The standard deviations from the Gillespie version are omitted for clarity. The
variance for the number of target cells (T) is high because in some cases the virus would
not infect any cells at all and the number of target cells remained constant (and high).
I compared the outputs of the Direct Method simulation with the difference equation
version. The means and variances of the ﬁnal outcomes appeared to be the same for
various initial conditions (Figure 3.2), but I was also concerned about the distribution
of outcomes, not just the low-order moments. To compare the distributions, I ran both
versions 100 times then took the histograms of the ﬁnal target cell, infected cell, and
virus levels. I initialized both systems with a small number of viruses (50) so that the
variance would be higher and the distribution of outcomes broader. The other parameters
corresponded to a typical acute virus infection: T0 = 106, I0 = 0, V0 = 50, l = 50000,
dT = 0.01, b = 2×10−7, dI = 0.7, p = 100, and c = 2.3. I recorded the system state at
the beginnings of days 2 and 5. The results from my simulation and the Gillespie model
seemed to have the same distributions at both time points (Figure 3.3).
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Figure 3.3: Comparison of the distribution of outputs of the difference equation model
and the Gillespie Direct Method version. The histograms (a)–(c) show the distribution of
target cell, infected cell, and virus populations at the beginning of day 2, while histograms
(d)–(f) are for the beginning of day 5. The ﬁlled gray histograms represent the Direct
Method outputs, while the open histogram bars are the difference equation outputs. The
averages from these runs are shown in Figure 3.2.
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The running time for a na¨ ıve implementation of the Gillespie Direct Method is at least
three orders of magnitude longer than the difference equation model I use. In my model,
it is assumed all probabilities (such as the probability that a cell becomes infected) can be
treated as constant during a time step. Using this assumption, the effects of the actions of a
population of identical cells during one time step can be computed in one operation. Using
larger time steps (such as 30 minutes) decreased running time but produced a noticeably
different distribution of outcomes than the Gillespie version, so I chose a 10-minute time
step for the simulation runs.
3.2 The T cell life cycle
CTL dynamics are represented in a stochastic stage-structured model of T cell activation,
proliferation, and differentiation. Infected cells from the infection dynamics model (de-
scribed in Section 3.1) stimulate na¨ ıve T cells and are killed by effector T cells (depicted
in Figure 3.4). The degree of T cell stimulation and infected cell clearance are determined
by receptor binding rules.
3.2.1 Receptor binding
CTLs detect antigens when their TCRs bind sufﬁciently well to MHC–epitope complexes
on the surfaces of the infected cells (Section 2.1.1). In the model, each antigen is associ-
ated with one or more epitopes, and each epitope is associated with an MHC type. A cell
infected by this antigen expresses these epitopes, which reveal to the immune system that
the cell contains pathogens. Each CTL in the model is associated with a single TCR speci-
ﬁcity (implying that each CTL expresses one kind of TCR), which can detect a particular
epitope. The strength of the binding interaction between the CTL’s TCRs and the MHC–
epitope complexes is deﬁned to be the binding afﬁnity. A TCR has high afﬁnity for its
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Figure 3.4: The process of infection and the life cycle of CTLs in the model. Target cells
are infected by virus, and these infected cells generate more virus and interact with T
cells. Na¨ ıve cells, when stimulated by antigen proliferate and become effector cells. The
probability of a na¨ ıve cell being stimulated by antigen depends on the string distance be-
tween the TCR and the antigen-MHC complex. Most effectors die, but about 5% of these
proliferating effector cells become memory cells. The memory cells can be stimulated to
become effectors in a secondary response (not shown).
cognate epitope, lower afﬁnity for related epitopes, and no afﬁnity for unrelated epitopes.
The model assigns afﬁnity values for each combination of TCR and epitope. The model
assigns each TCR a dissociation constant for each MHC–epitope complex, and afﬁnity is
inversely proportional to the dissociation constant. The model’s representation of TCRs,
MHC–peptide complexes, and the afﬁnities between them are described in Chapter 4.
A CTL successfully detects an infected cell when it has a high avidity for the cell. The
avidity that a CTL in the model has for an infected cell expressing a single epitope is the
product of its TCR’s afﬁnity for the epitope multiplied by a scalar value, e, representing
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the epitope’s surface expression density. Thus, a high-afﬁnity interaction can result in
low avidity if the epitope’s density is low. I assume that all cells infected with the same
pathogenhavethesameepitopedensities, makingthemallequallyantigenic. Ifaninfected
cell expresses multiple epitopes, a CTL’s avidity for it is the sum of its avidities for the
various epitopes.
3.2.2 Effector recruitment from the na¨ ıve and memory cell pools
Infected cells stimulate na¨ ıve and memory cells, causing them to differentiate into ef-
fectors. Because a relatively small number of na¨ ıve cells are recruited into an immune
response, I assume that they do not compete with each other for antigen, allowing the stim-
ulation of each na¨ ıve clone to be computed independently. Antigenic stimulation takes the
form of a saturating function (De Boer et al., 2001; Davenport et al., 2002):
Stimulation =
å
eiIi
Ki
1+å
eiIi
Ki
(3.13)
where Ki is the amount of antigen i required to generate half-maximal stimulation for the
T cell, ei is epitope density on cells infected by antigen i, and Ii is the number of infected
cells expressing antigen i in the system. This expression is in agreement with the obser-
vation that CTL recruitment is proportional to epitope density (Wherry et al., 1999), but
the response magnitude does not increase after a threshold density is reached (Vijh et al.,
1998). I assume that na¨ ıve T cells are recruited into the immune response at a rate of g
multiplied by the stimulation, where g = 1 day−1 is the maximum recruitment rate of T
cells.
Na¨ ıve T cells speciﬁc to a particular antigen are in the same stage until they are stim-
ulated. My model accommodates T cells of different antigen speciﬁcities by instantiating
separate stage-based models for each, but for the purposes of discussion I will assume that
there is only one T cell speciﬁcity. If there are multiple T cell clones, their execution order
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is permuted using a Fisher-Yates shufﬂe (Fisher and Yates, 1938), as is done for multiple
infectious agents. As na¨ ıve cells are stimulated, they must wait tn hours, representing
the developmental time before a na¨ ıve cell begins its programmed response. To imple-
ment this delay, the cells are promoted through a series of 6tn stages, with all cells in a
stage moving to the next stage at each 10-minute time step. The cells in these stages do
not interact with infected cells, but when they emerge after tn simulation hours, they be-
come effectors and start responding to infected cells and dividing. In my model, I assume
T cells take a minimum of 5 hours to divide, and that the ﬁrst T cell divisions take place
24 hours after antigenic stimulation (Oehen and Brduscha-Riem, 1998; Gett and Hodgkin,
2000; Veiga-Fernandes et al., 2000; van Stipdonk et al., 2001), so I chose tn = 19 hours.
Memory cells are recruited in the same manner as na¨ ıve cells except that I assume it
takes only one hour (tm = 1 hour) for a stimulated memory cell to begin its programmed
response, reﬂecting the rapid response of memory cells to pathogens (Bachmann et al.,
1999; Barber et al., 2003).
3.2.3 Clearance of infected cells
Because the CTL responses to different antigenic epitopes of the same pathogen do not
appear to interfere with each other (Vijh et al., 1999), I model the immune response to
multiple epitopes as the sum of independent responses to the individual epitopes. There-
fore, I need only deﬁne the clearance of infected cells expressing a single epitope by many
T cell clones. I assume that effector T cells of clone j, Ej, bind to infected cells I in re-
versible reactions (at rates kb for binding and kd for dissociation) to form complexes Cj,
and that effectors bound in these complexes clear the infected cells at rate kc:
Ej+I
kb
j
⇄
kd
j
Cj
kc
j → Ej (3.14)
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Directly translating the above expression to a differential equation:
˙ Cj = kb
j ˆ Ejˆ I−(kd
j +kc
j)Cj (3.15)
where ˆ Ej and ˆ I are unbound effectors and infected cells, respectively. Changing variables
to total cells and conserving the number of infected cells, as suggested in Borghans et al.
(1996), gives
˙ Cj = kb
j(Ej−Cj)(I−å
k
Ck)−(kd
j +kc
j)Cj (3.16)
where åkCk is the number of complexes of all effector cells of all speciﬁcities with I.
Assuming quasi-steady state:
0 = kb
j(EjI−CjI−Ejå
k
Ck+Cjå
k
Ck)−(kd
j +kc
j)Cj (3.17)
Following De Boer and Perelson (1995), I approximate the solution to equation 3.17 by
assuming the CjCk terms are small enough to be omitted:
Cj ≈
EjI−EjåkCk
I+Kj
(3.18)
where Kj =
kd
j+kc
j
kb
j
.
Following the derivation from the Appendix of De Boer and Perelson (1995), the so-
lution to equation 3.18 when there are multiple T cell clones is:
Cj ≈
IEj
Kj+I+åkEk
I+Kj
I+Kk
(3.19)
Therefore, the clearance rate of I due to effectors of all speciﬁcities is:
˙ I = −å
j
kc
jCj ≈å
j
−kc
j
IEj
Kj+I+åkEk
I+Kj
I+Kk
(3.20)
For a system with only one T cell clone, E:
˙ I ≈
−kcIE
K+I+E
(3.21)
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Expression 3.21 yields a dose-response relationship between effector cell numbers and
the infected cell clearance rate that saturates at kcI as the number of effector cells in-
creases, which agrees with experimental ﬁndings (Lehmann-Grube, 1988). It also includes
a term for inter-clonal competition among the effector cells for infected cells expressing
a single epitope. It appears that high- and low-avidity CTL lyse their targets at similar
rates (Derby et al., 2001), so I set kc to be the same for all T cell clones in my model. In
LCMV responses, the value of kc was found to be 12 day−1 (Barchet et al., 2000). Smaller
populations of T cells might have higher per capita killing rates, but I assume that most of
an infection is resolved while the effector cell population is large. In my model, increased
avidity K affects the ability to detect and bind to infected cells at low concentrations of I.
Multiple T cell clones clear infected cells at the rate described by equation 3.20, in which
T cells compete for access to infected cells based on their avidities to them. High-avidity
clones are more effective at clearing infected cells than low-avidity clones.
I assume that effector cell mediated clearance of infected cells is a Poisson process.
From equation 3.21, one can determine the expected number of infected cells to be cleared
in a time interval Dt to be ˙ IDt. I compute the number of infected cells that are cleared
during Dt by randomly drawing from the Poisson distribution P (˙ IDt) at each time step.
This term is subtracted from the right side of equation 3.5 to include the effect of cytotoxic
T cell clearance on the infected cell population.
3.2.4 T cell replication
I implement the programmed divisions of newly activated effector cells by keeping track
of the number of times a cell divides. When a na¨ ıve cell is ﬁrst stimulated, it joins the
cohort of effector cells that have not yet divided. When it reproduces, it is moved with
its daughter to the next division cohort. I adopt the transition probability cell cycle model
described by Smith and Martin (1973), which has two phases: an A phase with a variable
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residence time and a B phase that takes a ﬁxed length of time to traverse. Cells start
in phase A, in which the cells do not divide. At each time step, a cell has a constant
probability of entering phase B, during which it divides in a ﬁxed amount of time. At
the end of the B phase, both the parent cell and the new daughter cell enter the A phase.
This two-phase model enforces a minimum time to cell division. Without the ﬁxed length
B phase, some cells could divide an arbitrarily large number of times in a time interval,
which is a characteristic of continuous models of cell replication.
To implement the Smith-Martin cell cycle model, each division cohort is subdivided
into an A phase and a set of B phase sub-cohorts (Figure 3.5). To mimic the ﬁxed length of
time it takes a cell to traverse the B phase I allocate one B phase sub-cohort per time step
that the cells remain in B phase, and move cells from one sub-cohort to the next at each
simulation time step (Figure 3.5). I use 10-minute time steps, so to model cells remaining
in the B phase for n hours, I use 6nB phase sub-cohorts per division cohort. At each time
step, cells in the A phase of each division cohort transition to the B phase with a ﬁxed
probability.
I assume that the average cell cycle time of an effector T cell is 6 hours and that the
minimum time to division is about 5 hours (van Stipdonk et al., 2001). Therefore the du-
ration of the B phase is 5 hours and the average duration of the A phase is 1 hour. To
simulate a 5 hour B phase using 10-minute simulation time steps, I use 30 sub-cohorts.
To mimic the one hour average residence in the A phase, I assume the rate at which cells
in A phase transition to B phase is 1 hour−1. I convert this rate to the probability that
A phase cells will transition to B phase in a time step in the manner described in Sec-
tion 3.1 and draw from the binomial distribution to determine how many cells performed
the transition. Because T cells with different speciﬁcities seem to expand at the same rate
in vivo (Busch et al., 1998b), all cells in the model share the same cell cycle parameters.
When a death rate of dE = 0.6 day−1 is included (Veiga-Fernandes et al., 2000), the cell
population grows at a rate of 0.092 hour−1, or about 9-fold per day. T cells divide for
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A0 A1 A2
B0,0 B1,0 B2,0
B0,1 B1,1 B2,1    
B0,2 B1,2 B2,2
B0,3 B1,3 B2,3
B0,4 B1,4 B2,4
Figure 3.5: Implementation of the Smith and Martin two-phase cell cycle
model (Smith and Martin, 1973). Each box represents the cells in a given stage,
and the arrows represent possible transitions between stages. Note that cells in A phase
can either remain in A phase or transition to B phase, while B phase cells progress at a
ﬁxed rate until they reach A phase. In this ﬁgure, each B sub-stage is one hour, and in the
model implementation each sub-stage is 10 minutes.
about 5 days (Lehmann-Grube, 1988), which implies that a single na¨ ıve T cell can gen-
erate 60,000 effector cells, which agrees with experiment (Welsh and Selin, 2002). If one
assumes that a T cell cannot divide more than 100 times, there could to be up to 3100 sub-
populations of effector cells per T cell clone, or 100 A phase subpopulations and 3000 B
phase subpopulations. These 3100 subpopulations efﬁciently represent the approximately
600,000 cells (i.e., 10 na¨ ıve cells per clone (Casrouge et al., 2000) and 60,000 effectors
from each na¨ ıve cell) that can originate from a single clone in an immune response.
After their programmed divisions, the cells stop dividing (Badovinac et al., 2002). I
assume that during the entire lifetime of the activated T cell, they are subject to the same
high death rate dE. Thus, cell populations that have stopped dividing are subject to rapid
population decline.
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3.2.5 Memory
Some of the effector cells that proliferate during an immune response become long-lived
memory cells. In the model, effector cells have a 2% per day chance of becoming mem-
ory cells after 5 cell divisions (Oehen and Brduscha-Riem, 1998; Opferman et al., 1999),
which results in a ﬁnal memory pool that is about 5% of the peak response (De Boer et al.,
2001). The model assumes that all effector cells have an equal probability of converting
to memory. Like na¨ ıve cells, memory cells become effector cells upon antigenic stimula-
tion. I assume that memory cells have the same sensitivity to antigen as na¨ ıve cells, but
they enter cell cycle only one hour after antigenic stimulation. Memory-derived effector
cells have a lower death rate than na¨ ıve-derived effectors (Grayson et al., 2002), and I set
this rate to be dEm = 0.4 day−1 (Veiga-Fernandes et al., 2000). Because memory-derived
effectors have the same proliferation rate as na¨ ıve-derived effectors, this lower death rate
allows them to experience higher net population growth.
3.3 Summary
A virus infection model and a CTL model interact to form a system that can simulate the
CTL response to infection. The virus dynamics are adapted from a standard ODE model of
infection. The CTL model captures the behavior of individual T cells, but it uses a compu-
tationally efﬁcient stage-structured approach. Na¨ ıve CTLs are recruited into the immune
response by infected cells at a rate proportional to their afﬁnity to the antigen. Once re-
cruited, they become effector cells, which rapidly proliferate and eliminate infected cells.
After the response, some of these effector cells become long-lived memory cells while the
rest die. Memory cells are dormant until they are stimulated by infected cells, after which
they become effector cells. Many of the parameters used in the model are summarized in
Table 3.1.
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attribute value
time step (Dt) 10 minutes
na¨ ıve cell clone size 10 cells∗
maximum T cell recruitment rate (g) 1 day−1
delay before a stimulated na¨ ıve cell becomes an effector (tn) 19 hours†
delay before a stimulated memory cell becomes an effector (tm) 1 hour‡
na¨ ıve-derived active CTL death rate (dE) 0.6 day−1§
memory-derived active CTL death rate (dEm) 0.4 day−1§
time in B phase for CTL 5 hours 
average CTL cell cycle time 6 hours 
infected cell clearance rate (kc) 12 day−1¶
∗ Casrouge et al. (2000)
† Oehen and Brduscha-Riem (1998); Gett and Hodgkin (2000);
Veiga-Fernandes et al. (2000); van Stipdonk et al. (2001)
‡ Bachmann et al. (1999); Barber et al. (2003)
§ Veiga-Fernandes et al. (2000)
  van Stipdonk et al. (2001)
¶ Barchet et al. (2000)
Table 3.1: A summary of model parameters.
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Representing the CTL repertoire §
What is real is not the external form, but the essence of things...it is impos-
sible for anyone to express anything essentially real by imitating its exterior
surface.
—Constantin Brancusi
I’m afraid that if you look at a thing long enough, it loses all of its meaning.
—Andy Warhol
This chapter describes the model’s abstract representation of TCR–peptide interactions
that deﬁne the afﬁnities of CTLs for infected cells. The CTL model described in Chap-
ter 3 uses these afﬁnity values to govern the behavior of cells. TCRs and peptides are
represented as digit strings in the model, and the strength of interactions between them are
determined by the similarity between their strings, as deﬁned by a distance metric. Strings
are deﬁned in Section 4.1. The purpose of the model is not to mimic receptor–ligand
binding, but to have a representation that supports a realistic number of CTL clones with
different afﬁnities to antigen. Section 4.2 is a high-level description of the procedure used
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to generate the na¨ ıve CTL repertoire. This procedure is applied to create three different
versions of the model, each with a different deﬁnition of string distance. Comparing the
behavior of the three implementations in Chapters 5 and 6 will indicate how robust the
results are to assumptions about antigenic distance. The three metrics are deﬁned and cali-
brated in Appendix A. In the model, an antigen’s epitopes are subject to random mutation,
and this operation is deﬁned in Section 4.3. The CTL model described in Chapter 3 re-
quires afﬁnity, not string distance, be deﬁned, so the procedure for converting distance to
afﬁnity is in Section 4.4.
4.1 Strings and distances
Strings of digits represent the binding surfaces of receptors and ligands in
the model, an abstraction used by several immunological models in the
past (Farmer et al., 1986; Celada and Seiden, 1992; Detours et al., 1999; Smith et al.,
1999; Bernaschi and Castiglione, 2001). The digits can take any value between 0 and
k−1 inclusive, where k is the alphabet size. A random string, which one can think of as a
sequence of amino acids, is generated for each self peptide in the simulation. It has been
suggested that 103 −105 self peptides are involved in thymic selection (Bevan, 1997;
M¨ uller and Bonhoeffer, 2003; Bandeira and Faro, 2003), so the model creates 10,000
random “self peptide” strings for each of the three MHC alleles in the model. When a
new antigen type is created in the model, random peptide strings are created to represent
its epitopes. These strings represent the novel peptides that a cell infected with the antigen
expresses. Thus, all cells infected by this antigen are associated with the same set of
one or more epitope strings. Uninfected cells do not express any peptides in the model
because it is assumed that CTLs do not interact with healthy cells.
The organism represented by the model has three MHC alleles. Because I assume that
each distinct peptide in the “real” immune system is presented by a single MHC allele,
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TCR
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Figure 4.1: The digit string representation of TCR binding. Each T cell receptor, peptide,
and MHC type is represented by a digit string. Peptide strings are concatenated with
a string associated with one of the MHC types to form a single MHC–peptide complex
string. Afﬁnity is proportional to the similarity of the TCR string to the MHC–peptide
complex string.
each peptide string in the model is associated with exactly one of the three MHC alleles.
Because a TCR binds to both the peptide and parts of the MHC, each of the alleles is
associated with a random digit string to represent the portion of MHC visible to the TCR.
A peptide string is concatenated with its associated MHC’s string to form a single MHC–
peptide complex string that interacts with TCRs (Figure 4.1).
Each CTL in the simulation is assigned a randomly generated TCR string, which is the
same length as the MHC–peptide complex strings (Figure 4.1). The similarity between a
TCR string to an MHC–peptide complex string determines the afﬁnity that the CTL has
for an infected cell expressing that peptide. Each CTL is assumed to express many copies
of the same TCR, so a single TCR string is sufﬁcient to represent a CTL’s speciﬁcity for
antigen.
41Chapter 4. Representing the CTL repertoire
Antigenic distance, which has an inverse relationship with afﬁnity, is a measure of how
reactive an immune cell is to an antigen. If a CTL has a high afﬁnity for an epitope, then
it is antigenically close to it. In the model, a distance metric is used to formally deﬁne
the distance between a CTL and an MHC–peptide complex string. Distance is inversely
proportional to similarity. If the metric determines a TCR string and an MHC–peptide
complex string to be close (similar), then they have a high-afﬁnity interaction in the model.
The distance metric can be deﬁned in many ways, and the choice of metric might affect the
CTL model’s behavior. Therefore, I implement three different versions of the CTL model,
each using a different deﬁnition of distance. These metrics are deﬁned in Appendix A.
For all three metrics, the distance between two strings is the sum of the distances between
their corresponding digits. This constraint agrees with the observation that amino acid side
chains of peptides seem to make independent contributions to the binding energy with the
TCR (Hemmer et al., 1998).
4.2 Generating the na¨ ıve T cell repertoire
Thymic selection shapes the distribution of TCRs in the immune system, and the
CTL model uses an analogous process to generate its na¨ ıve CTL repertoire (de-
scribed in Section 4.2.1). A murine or human na¨ ıve repertoire consists of 106 − 107
clones (Pannetier et al., 1993; Arstila et al., 1999; Casrouge et al., 2000), which would be
computationally expensive to simulate. Because the purpose of the model is to observe
the response to a set of antigens, only the tiny fraction CTLs that can respond to these
antigens need to be instantiated. The procedure for generating only the responding CTLs
is described in Section 4.2.2. I have implemented versions of the CTL model using three
different distance metrics: Hamming, xor, and modiﬁed Manhattan distance. These met-
rics are deﬁned and calibrated for the CTL model in Appendix A, and a summary of this
calibration is presented in Table 4.2.
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4.2.1 Thymic selection
In the immune system, the fate of CTLs during thymic selection depends on their afﬁnity
for MHC–self peptide complexes. The model subjects random pre-selection TCR strings
to an analogous process. Random strings are generated to represent the TCRs of the pre-
selection CTL repertoire. The distance between each of these pre-selection strings and
all of the MHC–self peptide strings is computed. A positive selection process eliminates
CTLs with TCR strings that are too far from (dissimilar to) all MHC–self peptide com-
plexes, and a negative selection process eliminates those with TCRs that are too close
(similar) to any MHC-self complex. Only CTLs with TCR strings that are an intermedi-
ate distance from MHC–self peptide complexes survive to form the na¨ ıve repertoire. The
Mouse Human Hamming xor L′
1
# of self peptides 104−105∗ 30,000 30,000 30,000
# of MHC types 3 4 3 3 3
universe of TCRs (or #
of possible TCR strings)
1015† 1.47×1038 1.18×1021 1.13×1015
# of pre-selection clones < 109 1013 8×107 2.5×108 2.5×108
# of na¨ ıve clones 106−107‡ 107§ 3.17×106 2.02×106 1.95×106
foreign peptide response
frequency
10−5−10−6 8.39×10−6 1.27×10−5 1.43×10−5
thymic selection win-
dow size
1-3% 3.96% 0.807% 0.778%
% killed in negative se-
lection
50-66% 46% 61% 70%
# of clones per epitope 10-20  26.6 25.7 27.9
∗ Bevan (1997); M¨ uller and Bonhoeffer (2003); Bandeira and Faro (2003)
† Davis and Bjorkman (1988)
‡ Pannetier et al. (1993); Casrouge et al. (2000)
§ Arstila et al. (1999)
  Blattman et al. (2002)
Table 4.1: A summary of the values used to calibrate the different distance metrics. Bi-
ologically plausible values from studies of mice and humans are listed for comparison
with the model’s parameters.
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model computes positive and negative selection distance thresholds to eliminate most of
the random pre-selection CTLs, leaving only a small set of surviving na¨ ıve clones (Fig-
ure 4.2).
For a particular TCR string, I designate the nearest (most similar) MHC–self peptide
complex string as its “selecting” peptide. The distance between a CTL’s TCR string and
its selecting peptide determines whether or not the CTL survives thymic selection. If
the selecting peptide is too close, then the CTL is eliminated by negative selection; if it
is too far, then it is eliminated by positive selection. Non-selecting self peptides, which
are farther from the TCR than the selecting peptide, do not affect its chance of surviving
selection.
The model’s deﬁnition of the “intermediate distance” from self that ensures survival
of pre-selection CTLs is derived from mouse data. In mice, 1–3% of pre-selection T cells
survive thymic selection (Shortman et al., 1990), and about one-half to two-thirds of cells
that survive positive selection are eliminated by negative selection. Therefore the model
uses positive and negative selection thresholds such that 1–3% of pre-selection CTLs have
selecting peptides at distances between these two thresholds, and about 1–2 times more
pre-selection CTLs (i.e., 1–6%) have selecting peptides that are closer than the negative
selection threshold.
The positive and negative selection thresholds are found using the distribution of ex-
pected distances between a random TCR string and its selecting peptide. The distribution
was computed for each distance metric using the algorithm described in Detours et al.
(1999). The expected fraction of pre-selection CTLs eliminated by negative selection is
calculated by summing the distribution for all distances from zero to the negative selection
threshold (Figure 4.2). The expected fraction of CTLs eliminated by positive selection is
the summation of the distribution for all distances from the positive selection threshold to
inﬁnity. The CTLs that are between these two thresholds are in the “window” of distances
that survive thymic selection in the model. Various combinations of positive and negative
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Figure 4.2: The thymic selection window computation. The expected distribution of dis-
tances between a random pre-selection TCR and the nearest MHC–self peptide complex
is plotted. Positive selection eliminates the CTLs with TCRs that are to the “right” of the
positive selection threshold, while negative selection eliminates those to the “left” of the
negative selection threshold. Those that are between the two thresholds survive selection
and become na¨ ıve cells.
selection thresholds were tested to ﬁnd a combination that satisfy the constraints derived
from mouse data (Figure 4.2).
4.2.2 Lazy evaluation and the cross-reactive cutoff
Mice and humans have an estimated 106−107 na¨ ıve CTL clones (Pannetier et al., 1993;
Arstila et al., 1999; Casrouge et al., 2000), which exist to anticipate a seemingly inﬁnite
variety of pathogens. Most of these cells never have the opportunity to participate in a
response to antigen during the organism’s lifetime. A response to a single epitope usu-
ally involves only tens of CTL clones, and a single organism will be exposed to a limited
number of antigens. Thus, only a tiny fraction of na¨ ıve CTLs will ever play a signiﬁcant
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role in clearing infections from an organism. In a simulation, we are interested only in
this fraction. In fact, a “newborn” simulated organism would not need any na¨ ıve CTLs
until it is exposed to antigen. Immediately before each exposure to antigen, the simulation
can instantiate the cells that can respond to that particular antigen if they were not already
created in a prior exposure to antigen. In this manner, only the CTLs that play an active
role in the simulation are explicitly created. This procedure was formalized in Smith et al.
(1998), in which the author adapts computer science’s concept of lazy evaluation to de-
termine which cells actually need to be instantiated. By creating only the cells that are
necessary, the simulation is orders of magnitude more efﬁcient.
Most CTLs are too antigenically distant from any given epitope to have any afﬁnity
for it, so only the tiny fraction of CTLs that have afﬁnity for the antigen’s epitopes are
instantiated in a “lazy” simulation. The cross-reactive cutoff is the antigenic distance
from an epitope beyond which immune cells, such as B or T cells, have negligible afﬁnity
for the epitope. Thus, when a simulation introduces a new antigen, only the na¨ ıve CTLs
that are closer than the cross-reactive cutoff of the antigen’s epitopes are created. In the
model, the cross-reactive cutoff for MHC–foreign peptide complexes is set to be equal
to thymic selection’s negative selection threshold for MHC–self peptide complexes. This
is based on the assumption that the purpose of negative selection is to rid the body of
self-reactive CTLs, so the cells that could react to MHC–self peptide complexes in the
body (i.e., those within the cross-reactive cutoff of these complexes) are exactly those that
are removed by negative selection (i.e., those within the negative selection threshold). If
only 10−5 of the repertoire responds to an epitope (Stockinger et al., 1980; Zinkernagel,
1996), then using lazy evaluation can reduce the number of cells created in a simulated re-
sponse to an epitope by 5 orders of magnitude. In the past, modelers used artiﬁcially small
repertoires (Kleinstein and Seiden, 2000) or required substantial computing resources to
simulate a realistic-sized repertoire (Detours and Perelson, 2000). In my model, all of the
active cells of a realistic-sized repertoire are represented.
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Figure 4.3: Lazy evaluation of CTLs. The pre-selection repertoire for a single epitope
is depicted in Figure a). The × represents an MHC–epitope complex, and ﬁlled circles
represent pre-selection CTLs. The distance between the epitope and a CTL in the ﬁgure
is proportional to their antigenic distance. The pre-selection repertoire is generated by
creating CTLs at each distance from 0 to the cross-reactive radius from the MHC–epitope
complex. Figure b) depicts the repertoire after thymic selection against a single MHC–self
peptide complex. Thymic selection eliminates those that are within the negative selection
thresholds of any MHC–self peptide complex and those that are outside the positive selec-
tion thresholds of all MHC–self peptide complexes. The CTLs that do not survive thymic
selection are drawn as empty dashed circles. The surviving cells (ﬁlled circles) mature to
become na¨ ıve CTLs.
The ﬁrst step in instantiating the CTLs that can respond to a particular epitope is to cre-
ate a pre-selection repertoire for the epitope. Using lazy evaluation, only the pre-selection
repertoire that is within the cross-reactive cutoff of the MHC–epitope complex is gen-
erated. These CTLs form a “sphere” of strings surrounding the MHC–epitope complex
with a radius equal to the cross-reactive cutoff (Figure 4.3a). These CTLs can be created
by generating random strings that are at distance 0 from the complex, then at distance 1,
and so on until the cross-reactive cutoff distance is reached. See Smith et al. (1998) for a
detailed description.
The number of CTLs that should be generated at each distance is based on the number
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one would expect to ﬁnd at each distance if all of the clones of the pre-selection repertoire
were explicitly generated. For example, if the simulation uses MHC–peptide complex
strings of length 10 and an alphabet of size 20, then the number of possible strings is 2010,
or about 1013. Of these strings, only one is exactly the same as the complex’s string. If
the simulated organism has a pre-selection repertoire size of 108 CTLs, then the expected
number of clones at distance 0 from the complex is 108/1013 = 10−5. The expected num-
ber of clones for distances greater than 0 depends on the particular distance metric chosen,
and the calculations for each distance metric are described in Appendix A. The actual
number of clones at each distance is chosen by drawing a random number from the bino-
mial distribution with the expected value as the mean.
Once the number of pre-selection TCR strings at a given distance from an MHC–
epitope complex is determined, random TCR strings are generated using the algorithms
described in Appendix A. If the repertoire for one or more other MHC–epitope complexes
was generated before, then care must be taken so that these new pre-selection CTLs do not
“overlap” with them. When a new pre-selection TCR string falls within the cross-reactive
cutoffs of a previously encountered epitope, that TCR is eliminated. These TCRs are in
the region of TCR space that is stimulated by the current MHC–epitope complex and a
previous one. Therefore, the TCRs in this region are created by lazy generation upon
exposure to the ﬁrst complex, and the second complex can stimulate those previously
generated TCRs rather than create extra ones in this region covered by the other complex.
After the pre-selection cells are generated, they are subjected to a thymic selection
process against all MHC–self peptide complexes. The distances between each clone and
each MHC–self peptide complex is computed, and those clones that are too close to one of
the self complexes or too far from all of them are eliminated (Figure 4.3b). The remaining
clones enter the na¨ ıve repertoire.
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4.3 Mutation
Genetic mutation is one of the many mechanisms that viruses have evolved to evade the
immune response. When antigens replicate in the body, mutations can change or even
eliminate the epitopes that cells infected by this antigen express. Over the course of an
infection, random mutations can accumulate in an antigen’s lineage, generating multiple
competing variant strains in a single host. The CTL model implements antigenic mutation
so these effects can be studied.
I assume that mutation makes random changes to the viral genome when it replicates,
so the mutation rate in the CTL model is expressed as a probability of mutation per replica-
tion event. A mutation changes an antigen’s epitopes by setting a single randomly chosen
portion of an antigen’s epitope string to a random value. For the xor and modiﬁed Manhat-
tan distance versions, a mutation changes only a randomly chosen single digit. Because
the Hamming distance version of the model uses much longer epitope strings (see Ap-
pendix A.1), strings are divided into groups of 8 digits, and a mutation sets all 8 digits of
one randomly chosen group to random values.
In the CTL model, the number of mutations that occur depends on the virus dynamics.
Recall the equations that govern virus dynamics from Section 3.1:
DT = (l−dTT −bTV)Dt, (4.1)
DI = (bTV −dII)Dt, (4.2)
DV = (pI−cV)Dt (4.3)
If one assumes that mutations occur when viruses replicate within a host cell, then the
number of new mutant viruses that arise per time step is proportional to the virus produc-
tion rate, pIDt from Equation 4.3. However, most of these new viruses will die (the cV
term) without infecting cells, so there is no need for the simulation to generate all of the
mutants. It is more efﬁcient to create the mutants as cells are infected because only the
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viruses that successfully infect a cell affect the host. Cells are infected at rate bTVDt,
so the number of new mutant cells generated in a time step is drawn from the binomial
B(bTVDt,p), where p is the mutation rate. The epitopes expressed by the original anti-
gen are changed for each of these new mutants. Thus, each mutation event creates a single
infected cell expressing what is likely to be a unique epitope.
Because a newly mutated antigen strain has an altered epitope, some of the CTLs
that had responded to the original antigen will not respond to it. Figure 4.4 shows the
distribution of the number of CTLs that can respond to one epitope and the number of
those that can recognize the mutated epitope. For the results shown in this ﬁgure, mutation
was performed by setting the ﬁrst digit(s) of the epitope string to 0, so the peptide was
unchanged if the digit was originally 0. For both the xor and L′
1 metrics, about half of the
mutations changed the epitope enough that none of the CTLs that had responded to the
original epitope recognized the new epitope. In the Hamming metric version, mutation
never allowed the epitope to evade all of the clones that had responded to the original.
4.4 Converting distance to afﬁnity
The CTL model described in Chapter 3 requires that the afﬁnity between a TCR and an
MHC–peptide complex be deﬁned. Afﬁnity, which is the strength of the interaction be-
tween a TCR and an MHC–peptide complex, determines the rate at which quiescent CTLs
are recruited into a response (Section 3.2.2) and how rapidly a particular clone clears in-
fected cells (Section 3.2.3). The strength of interactions between TCRs and MHC–peptide
complexes is proportional to their string distances in the model.
In the immune system, TCRs have sensitivities for antigen that can differ by orders of
magnitude. Therefore, the afﬁnity decreases exponentially with respect to string distance
inthemodel. Afﬁnitiesaredeﬁnedforeachofthethreeversionsofthemodebycomputing
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(a) Hamming (b) xor
(c) Manhattan
Figure 4.4: The repertoire overlap between mutated epitopes. TCRs were generated
around a foreign peptide–self MHC complex. The distribution of the number of TCRs
is indicated by the solid line. The epitope was mutated, and the distribution of the number
of TCRs from the original epitope that could respond to the new one is indicated by the
dashed line. The peptide was mutated by eight digits for the (a) Hamming results and by
one digit for the (b) xor and (c) L′
1 results. Results shown are the distribution of 1000
trials.
a dissociation constant, K, based on distance:
Kxor = 5,000+15,000×e(Dxor−115)/3 (4.4)
KH = 5,000+5,000×e2×(DH−31) (4.5)
KL1′ = 5,000+10,000×e2×(DL1′−15) (4.6)
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where Dxor is the xor distance, DH is the Hamming distance, and DL1′ is the modiﬁed
Manhattan distance. Afﬁnity is inversely proportional to the dissociation constant (see
Section 3.2.2). The constants in Equations 4.4–4.6 were chosen so that each epitope has
a few high-afﬁnity clones in the na¨ ıve repertoire (K in the range of 5000−10000) and
that the low-afﬁnity clones have a dissociation constant that is between 105 −107. The
distribution of na¨ ıve clone distances from and afﬁnities for an MHC–epitope complex is
shown in Figure 4.5. The afﬁnity distributions for the different distance metrics could not
be made equal, but they are qualitatively similar.
4.5 Summary
The CTL model uses digit strings to represent TCRs and MHC–peptide complexes. The
afﬁnity that a CTL has for an MHC–peptide complex is proportional to the similarity of
the digit strings corresponding to the CTL’s TCR and the complex, where similarity is
deﬁned by a string distance metric. Three versions of the model, each using a different
distance metric (Hamming, xor, and modiﬁed Manhattan distance), are calibrated to match
known thymic selection characteristics in mice. The model implements a process that
represents thymic selection to produce a na¨ ıve CTL repertoire. The model represents an
organism with 106−107 CTL clones, but most of these clones do not need to be explicitly
generated in a simulation. By creating only the TCRs that can respond to the epitopes used
in a particular simulation, the simulation realizes an enormous savings in computation
and memory, sometimes by as much as a factor of 105. An epitope mutation operation
is deﬁned to allow the model to simulate the evolution of pathogens in a host. Finally,
formulas for converting string distances to the afﬁnity values are given.
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Figure 4.5: The distances of TCRs from an MHC–foreign peptide complex. CTL clones
for a foreign peptide were generated using lazy evaluation. The distribution of distances
between the clones and the foreign peptide-self MHC complex is plotted for (a) Hamming
distance, (b) xor distance, and (c) modiﬁed Manhattan distance. The plots represent av-
erage results from 100 runs. In (d), the results in (a)–(c) are converted to afﬁnities using
Equations 4.4–4.6. The histogram plots the number of clones with a given afﬁnity for the
complex. Each bin of the histogram is larger than the preceding bin by a factor of 10. The
solid bars represent Hamming distance, the diagonal bars represent xor distance, and the
cross-hatched bars represent modiﬁed Manhattan distance.
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If you know exactly what you’re going to do, what’s the good in doing it?
—Pablo Picasso
The deﬁnition of insanity is doing the same thing over and over and expecting
different results.
—Benjamin Franklin
The CTL model reproduces phenomena seen in cell culture and in laboratory mice.
The effects that thymic selection has on the model’s na¨ ıve CTL repertoire are described
in Section 5.1. Section 5.2 illustrates the basic dynamics of the acute CTL response us-
ing only one or two clones per epitope. A realistic number of clones is introduced in
Section 5.3, which describes the clonal composition of responses. Most of the results
presented in Sections 5.2 and 5.3 were ﬁrst published in Chao et al. (2003), Chao et al.
(2004a), and Chao et al. (2004b).
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5.1 Consequences of thymic selection
Thymic selection transforms a random CTL repertoire into one that can detect foreign
peptides while ignoring self peptides. The model’s implementation of thymic selection
performs an analogous function on a set of random TCR strings, and its effects can be
observed by comparing the repertoire before and after selection. Even though the model
creates three MHC alleles and mice and humans generally express more than one, I dis-
cuss many of the results as if there were only one MHC type. I assume that MHC restric-
tion (Zinkernagel and Doherty, 1974) is strong enough that a CTL can only interact with
peptides presented on the MHC type that presented its selecting peptide in the thymus.
This assumption simpliﬁes the following discussion without loss of generality.
5.1.1 CTL repertoire coverage of foreign peptides
The number of foreign peptides that a CTL repertoire can recognize in the model is a
function of the number of clones. I deﬁne coverage as the percentage of foreign peptides
that are detected by at least one CTL clone. Figure 5.1 plots the relationship between the
number of na¨ ıve clones and coverage, which initially increases with the number of clones
then quickly saturates. To determine the foreign peptide coverage of a CTL repertoire,
I generated 10,000 random “foreign” peptide strings and counted the fraction that was
detected by the model’s CTL repertoire, which is randomly generated. Because I was
measuring the coverage of a whole repertoire, the CTLs were explicitly generated and
subjected to thymic selection against 30,000 self peptides, and lazy evaluation was not
used.
The probability that a foreign peptide is “covered” by at least one clone can be esti-
mated using the foreign peptide response frequency f, which is calculated for each of the
distance metrics used by the CTL model in Appendix A. If a single CTL covers a fraction
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Figure 5.1: Foreign peptide coverage by CTLs. 10,000 random foreign peptide strings
were generated and each was associated with one of three MHC types. In (a), the fraction
of these MHC–foreign peptide complexes detected by at least one CTL of a set of n clones
is plotted against the size of the repertoire for Hamming (◦), xor (⋄), and L′
1 (+) distance
versions of the model. In (b), the fraction not covered is plotted. The lines indicate the
expected values using Equation 5.1.
f of all possible foreign peptides, then the fraction of space not covered is 1− f. The
probability that a foreign peptide is not covered by a set of n distinct CTLs is (1− f)n.
Thus, the foreign peptide coverage An of n clones is:
An = 1−(1− f)n (5.1)
This prediction ﬁts results from the model for all distance metrics (Figure 5.1). This
indicates that coverage can be estimated accurately using only the foreign peptide response
frequency, without considering the other properties of the distance metrics. This result
also implies that the CTLs that survive selection cover the space of foreign peptides with
the same efﬁciency as one would expect of the same number of randomly generated pre-
selection CTLs.
An effective CTL response requires multiple clones per epitope, so coverage of an
antigen’s epitopes by a single clone does not guarantee its clearance by the immune sys-
tem. To estimate the probability that a foreign peptide is covered by multiple clones, I ﬁrst
determine the probability that a foreign peptide is covered by exactly m clones out of a
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repertoire of size n:
An,m = fm(1− f)n−mC(n,m) (5.2)
whereC(n,m) is the number of distinct combinations of m objects that can be drawn from
a set of n and is equal to n!
(n−m)!m!. It has been observed that 10–20 clones respond to an
immunodominant LCMV epitope in mice (Blattman et al., 2002), so I will assume that an
effective response requires at least 10 clones per epitope. The probability that an epitope is
covered by 10 or more clones is equal to 1 minus the probability that the epitope is covered
by fewer than 10 clones:
¥
å
i=10
An,i = 1−
9
å
i=0
An,i (5.3)
This function is plotted and compared to results from the model in Figure 5.2. The
probability that a foreign peptide is detected by enough na¨ ıve CTL clones to mount an
effective response reaches 99% when the number of na¨ ıve clones is between 106 and
107, which happens to be the number of CTL clones in a mouse (Pannetier et al., 1993;
Casrouge et al., 2000).
5.1.2 CTL afﬁnity for MHC is correlated with afﬁnity for self pep-
tides
In the model, thymic selection eliminates CTLs solely on the basis of their afﬁnities for
MHC–selfpeptidecomplexes. Beforeselection, TCRstringsarerandom, soaTCR’safﬁn-
ity for MHC is independent of its afﬁnity for self peptides. Thymic selection introduces a
dependence between a surviving CTL’s afﬁnity for MHC and its afﬁnity for peptide. After
selection, afﬁnity for MHC has an inverse relationship with afﬁnity for self peptides (Fig-
ure 5.3). Because thymic selection allows only CTLs with a very narrow range of afﬁnities
for their closest MHC–self peptide complexes to survive, if a surviving CTL has a certain
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Figure 5.2: Foreign peptide coverage by at least 10 CTLs. 10,000 random foreign peptide
strings were generated and each was associated with one of three MHC types. In (a), the
fraction of these MHC–foreign peptide complexes detected by at least ten CTLs of the
model’s na¨ ıve repertoire is plotted against the size of the repertoire for xor (⋄) and L′
1 (+)
distance versions of the model. In (b), the fraction not covered is plotted. The size of
the repertoire that could be created by the model was limited by the computer’s memory
capacity, so there are no empirical results for large numbers of clones. The lines indicate
the expected values using Equation 5.3.
afﬁnity for its selecting peptide, then its afﬁnity for MHC must fall within a very narrow
range for it to have survived selection.
The MHC-binding portion of a TCR determines its peptide binding degeneracy, which
is a measure of the number of different peptides with which a single TCR can bind. Be-
cause TCRs bind to peptide presented by MHC, those having high afﬁnity for MHC can
bind to a much larger set of peptides, and thus have a higher degeneracy, than those that
bind poorly to MHC. Therefore, peptide binding degeneracy and afﬁnity for MHC are cor-
related. The afﬁnity of a thymically selected CTL for self peptide and its peptide binding
degeneracy are so closely linked that the standard explanations for the roles of negative
and positive selection are reconsidered in the following sections.
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Figure 5.3: Thymic selection introduces a dependency between MHC and self-peptide
afﬁnity in CTLs. For 100 random foreign peptides presented by MHC, realistic-sized pre-
and post-thymic selection repertoires were generated using lazy evaluation. The antigenic
distance between each TCR’s peptide-binding region and its selecting self peptide is on
the x-axis, and the distance between each TCR’s MHC-binding region and the presenting
MHC is on the y-axis. Three distance rules were tested: (a) Hamming, (b) xor, and (c)
modiﬁed Manhattan distances. The pre-selection TCRs are represented by light ×s, and
the post-selection TCRs by black ◦s.
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5.1.3 Negative selection increases peptide binding speciﬁcity
Immunologists assume that negative selection eliminates CTLs with high afﬁnity for self
peptides. In the model, negative selection eliminates CTLs with high afﬁnity for MHC–
self peptide complexes, so both CTLs with high afﬁnity for self peptides and those with
high afﬁnity for MHC are removed. Figure 5.4 compares the pre-selection CTL reper-
toire with the repertoire that survives negative selection. Comparing the distribution of
distances between TCRs and MHC before and after negative selection (without subjecting
them to positive selection), one can see that negative selection decreases the average afﬁn-
ity for MHC. By eliminating TCRs with high afﬁnity for MHC, negative selection only
allows those with higher speciﬁcity for their cognate peptides to survive. This agrees with
the suggestion that negative selection increases the speciﬁcity that TCRs have to foreign
peptides (Huseby et al., 2003; Slifka et al., 2003).
TCRs can be generated in vitro so that they are not subject to thymic selection. In
Holler et al. (2003), TCRs were selected in vitro to have high afﬁnity for a particular set
of MHC–foreign peptide complexes. In the experiment, it was found that cells expressing
these TCRs tended to react to self peptides (Holler et al., 2003). One would expect these
CTLs to have high afﬁnity for both the foreign peptide and its presenting MHC. The
consequence of having high afﬁnity for MHC would be highly degenerate peptide binding,
allowing them to react to self peptides also. Presumably, these cells would have been
eliminated by negative selection because of their high afﬁnity for MHC, not because they
have high afﬁnity for a self peptide.
5.1.4 Positive selection maximizes peptide binding degeneracy
It is widely believed that the purpose of positive selection is to eliminate CTLs with such
low afﬁnity for MHC that they would not be likely to bind to foreign peptides presented
by MHC. Some have even suggested that self peptides are just “stand-ins” for foreign
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Figure 5.4: Effects of negative selection on TCR distance to foreign peptides. A pre-
selection TCR repertoire was lazily generated for a single foreign peptide presented by
MHC. This repertoire was then subjected to negative but not positive selection. The
distributions of antigenic distances from the MHC–foreign peptide complex to TCRs from
the pre- and post-selection repertoires are plotted. The number of TCRs at each distance
from the MHC–foreign peptide are indicated by ◦ for the pre-selection repertoire and • for
the post-selection repertoire. The number of TCRs whose peptide-binding region are at
each distance from the foreign peptide are indicated by   for the pre-selection repertoire
and   for post-selection. The number of TCRs whose MHC-binding region are at each
distance from the MHC that presented the foreign peptide are indicated by △ and the dark
shaded region for the pre-selection repertoire, and   and the light shaded region for the
post-selection distribution. Three distance measures were used: (a) Hamming, (b) xor, and
(c) modiﬁed Manhattan. The results shown are the averages from 1000 different trials for
each distance metric.
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peptides during positive selection (Goldrath and Bevan, 1999). I believe that self peptides
play an essential but overlooked role in positive selection. Although positive selection in
the model tends to eliminate CTLs with low afﬁnity for MHC, some of these CTLs can
be “rescued” by having high afﬁnity for a self peptide. Conversely, CTLs with moderate
afﬁnity for MHC can be “damned” by having low afﬁnity for all self peptides. There-
fore, positive selection does not simply purge the repertoire of CTLs with low afﬁnity
for MHC—it removes CTLs that have “sub-optimal” afﬁnity for MHC given the CTL’s
afﬁnity for its selecting peptide.
This hypothesis can be tested using engineered thymic selection environments with
only one positively selecting peptide. In Kraj et al. (2001), the speciﬁcities of two of CTLs
positively selected on a single MHC–peptide complex were characterized. One CTL was
very speciﬁc to a peptide similar to the selecting peptide. The other CTL was speciﬁc to
a peptide that was unrelated to the selecting peptide, and it had a high peptide binding
degeneracy. I postulate that the ﬁrst CTL had a high afﬁnity for the selecting peptide and
a low afﬁnity for MHC, and the second had low afﬁnity for the peptide and high afﬁnity
for MHC. More studies will be needed to determine the relationship between the afﬁnities
that CTLs have for self peptide and for MHC.
5.1.5 Epitopes and self peptides
Although the CTLs in the model have “maximal” peptide binding degeneracies, the CTLs
that are close to self peptides have lower peptide binding degeneracies. Epitopes that are
close to self peptides would be covered by these highly speciﬁc CTLs. In the model, the
average binding degeneracy of CTLs that have afﬁnity for an epitope is correlated with the
epitope’s distance from the nearest self peptide for two of the three distance metrics tested
(Figure 5.5). For the Hamming distance version (Figure 5.5a), the binding degeneracy is
not affected by the distance between the epitope and self peptides. This divergence from
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Figure 5.5: CTL to MHC distance vs. distance between an epitope and its closest self pep-
tide. 10,000 random epitopes were generated, and the distances between these epitopes
and their nearest self peptides were measured. A new CTL repertoire was created for each
of these epitopes, and the average and standard deviation of the distances from their TCRs
to the MHC presenting the epitopes is plotted against the epitope–selecting peptide dis-
tance. The TCR–MHC distance determines a CTL’s foreign peptide response frequency,
and the corresponding frequency for each distance is displayed on the y-axis on the right
of each plot. The results shown are from simulations using three distance metrics: (a)
Hamming, (b) xor, and (c) modiﬁed Manhattan distances.
the other distance metrics (xor and modiﬁed Manhattan) could be a property of Hamming
distance or it might simply be the choice of Hamming distance parameters used by the
model.
The peptide binding degeneracy of CTLs could affect the ability of the immune system
to eliminate a mutating pathogen. Pathogens can escape the immune system’s response
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when their epitopes mutate. These modiﬁed epitopes might not be recognized by the
CTLs that respond to infected cells expressing the original epitope, so the immune system
would need to mount a new response against the mutant. A CTL with high peptide binding
degeneracy might be able to recognize both an epitope and its variants, which would make
it difﬁcult for a new mutant to survive. Thus, even a quickly mutating pathogen would
generate few surviving variants so its “effective” mutation rate would be low. A CTL that
is too speciﬁc could be easier to escape through mutation. If most CTLs responding to
an epitope that is similar to a self peptide are highly speciﬁc, then the antigen’s variants
would have a greater chance of surviving the immune response. Because their mutated
progeny would be the most viable, such antigens would have the highest “effective” muta-
tion rates. If the effective mutation rate increases as the epitopes become more similar to
self peptides, then the immune system drives the pathogen to express epitopes that mimic
self. Once an epitope is sufﬁciently similar to a self peptide, the immune system would be
unable to detect it because negative selection eliminates CTLs too close to self.
5.1.6 Na¨ ıve repertoire generation efﬁciency
The generation of the na¨ ıve CTL repertoire is an expensive process, both in the body
and in the model. If over 95% of randomly generated CTLs are purged during thymic
selection, then for each CTL that joins the na¨ ıve repertoire, over 19 are eliminated in
the thymus. I measured the efﬁciency of CTL generation in the model. On average 30
CTL clones respond to each epitope, so one would expect the model to generate 20×30
= 600 pre-selection CTL clones per epitope. In practice, only about 10 pre-selection CTL
clones are generated to produce each na¨ ıve clone (in Table 5.1, divide the number of CTL
clones generated by the number surviving selection), or about 300 pre-selection clones per
epitope.
This efﬁciency in the model appears to be a consequence of using lazy evaluation (Sec-
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Hamming xor L′
1
number of pre-selection clones 8×107 2.5×108 2.5×108
thymic selection window 34 140–149 19
number of CTL clones generated 222.8 ± 14.9 230.9 ± 15.0 359.9 ± 18.4
clones killed in positive selection 31.3 ± 5.9 40.0 ± 13.6 53.9 ± 17.4
clones killed in negative selection 164.9 ± 13.1 168.1 ± 19.4 278.0 ± 24.2
clones surviving selection 26.6 ± 5.1 23.1 ± 5.5 27.9 ± 6.4
Table 5.1: The efﬁciency of T cell repertoire generation in the model. A pre-selection
repertoire was generated around a single MHC–foreign peptide complex using lazy eval-
uation. This repertoire was subjected to positive and negative selection to produce na¨ ıve
CTL clones. The average and standard deviation for 1000 trials for each of the three
distance metrics are shown.
tion 4.2.2). The model uses lazy evaluation so that it does not generate the pre-selection
CTLs that are outside the cross-reactive cutoff of an MHC–epitope complex, reducing the
computational and memory requirements of the simulation by several orders of magnitude.
However, lazy evaluation introduces an unexpected additional efﬁciency gain.
In the “real” immune system, it is believed that positive selection eliminates more pre-
selection clones than negative selection: about 95% by positive selection and <5% by neg-
ative selection (Section 4.2.1). In the model, these proportions are reversed—about 75% of
pre-selection clones speciﬁc to a single MHC–epitope complex are eliminated by negative
selection, and only about 15% are eliminated by positive selection (Table 5.1). If the role
of positive selection is to rid the body of pre-selection CTLs that are unlikely to respond to
any MHC–epitope complexes, then lazy evaluation makes this task less important because
it already ensures that all pre-selection CTLs generated are within the cross-reactive radius
of an MHC–epitope complex. If the model generated all pre-selection clones, and not just
the ones that could respond to an epitope, then positive selection would eliminate a higher
proportion of cells. This hypothesis could be tested in the lab by measuring the number of
pre-selection clones that respond to a particular MHC–epitope complex, then comparing
this to the number that are eliminated by positive and negative selection. I believe that
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negative selection would eliminate more pre-selection clones than positive selection.
Although the cells purged by positive selection would have been capable of responding
to antigen, there is a tradeoff between the cost of maintaining these cells and the possi-
ble beneﬁt of having them during an immune response. For many pre-selection cells, the
probability of their responding to an antigen during an organism’s lifetime is dispropor-
tionately small, and positive selection preferentially eliminates them. Although positive
selection eliminates about 95% of all pre-selection CTLs in the body, the model indicates
that positive selection reduces the number that could respond to an epitope only by about
60% (in Table 5.1, divide the number of clones killed in positive selection by the sum of
the number killed in positive selection and the number of clones surviving selection).
5.1.7 Is the TCR repertoire optimized to detect foreign peptides?
There is a striking similarity between the model’s CTL repertoire and Reduced Coulomb
Energy(RCE)networks(Reilly et al.,1982). RCEnetworksareusedtoclassifyinputsinto
various categories. During a training phase, they are exposed to examples from each of the
desired categories. Every training example is assigned a radial basis function detector. A
detector is a hypersphere that covers a set of input values similar to each example, and any
input that falls within a detector is considered to be of the same category as the example
associated with the detector. The radius (size) of each detector is adjusted so that it covers
as much of input space as possible without covering a training example from a different
category. Thus, RCE networks attempt to cover as much of input space as possible without
misclassifying inputs.
The model’s CTL repertoire behaves like an RCE network. CTLs are radial basis func-
tion detectors that cover portions of peptide space classiﬁed as “foreign.” The regions that
are not covered by CTLs are implicitly considered “self.” Like radial basis function detec-
tors, CTLs can cover different-sized portions of space based on their peptide binding de-
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generacies. Unlike standard RCE networks, the CTL repertoire is trained using examples
from only one category—pre-selection CTLs are exposed to self peptides in the thymus.
Therefore, rather than tuning detectors like an RCE network, the CTL model creates an
excess of random detectors and eliminates those that are not optimal (Figure 5.6). These
pre-selection CTLs must be screened to eliminate those that detect self peptides, a task
accomplished by negative selection. Positive selection eliminates CTLs that do not cover
enough peptides. Like the RCE network detectors, CTL coverage should be as broad as
possible without covering a self peptide. The farther the distance between the CTL and
its selecting self peptide, the more degenerate its peptide binding should be. Although the
generation of CTLs is quite different than the RCE network training approach, the set of
detectors that is generated by these processes have similar properties.
I believe that foreign peptide coverage is improved by using smaller detectors close to
self and larger detectors that are far from self. Using different-sized detectors gives the
immune system the ability to increase the ﬁneness of foreign peptide coverage near self
peptides, regions in which it must be highly discriminating, and have coarser coverage
farther from self peptides. Thus, the wide range of peptide binding degeneracies observed
in the lab could be a key component of antigen detection.
5.2 Basic dynamics of the CTL response
The following experiments illustrate the basic properties of the model using only one or
two CTL clones. Although CTL responses normally involve many clones (and this case is
covered in Section 5.3), it is easier to analyze the behavior of a single large population of T
cellssharingthesamespeciﬁcity. Thevirusinfectionparametersusedintheseexperiments
are in Table 5.2.
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Figure 5.6: Thymic selection optimizes foreign peptide coverage. Figure (a) is a represen-
tation of the pre-selection CTL repertoire. Self peptides are denoted as ×s, and the CTLs
are represented as circles, with the areas covered by each circle representing the peptides
that the CTLs can bind. The distances between the ×s and the centers of the circles are
proportional to the antigenic distances between the self peptides and the peptide-binding
portions of the TCRs. In (b), CTLs that are eliminated during positive selection are indi-
cated with dashed lines. CTLs that are eliminated by negative selection are indicated with
dashed lines in (c). The CTLs that survive thymic selection are shown in (d).
5.2.1 Primary and secondary immune responses
I simulated the primary and secondary responses to an acute infection (Figure 5.7). For
this trial, I was interested in testing the overall dynamics of the T cell response in the
model rather than attempting to match the results to a particular laboratory experiment. I
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attribute value
susceptible cell population (T) 106 cells
susceptible cell production rate (l) 105 cells/day
susceptible cell death rate (dT) 0.1 day−1
virus infection rate (b) 2×10−7
virus production rate (p) 100 day−1
virus clearance rate (c) 2.3 day−1
infected cell death rate (dI) 0.8 day−1
Table 5.2: A summary of infection parameters used in Section 5.2.
simulated the injection of 500 viral units into a mouse with a single high-afﬁnity T cell
clone of 50 cells. The primary response began after approximately one day. It peaked at
day 9 then declined and formed a stable memory pool. At day 28, an identical injection
was administered, and the secondary response was faster and larger than the primary (Fig-
ure 5.7). The secondary response began almost immediately after secondary exposure to
the virus, and the lower death rate of memory-derived effectors caused the T cell popula-
tion to increase more rapidly. The secondary response also created a larger pool of stable
memory cells. Therefore, the simulated mouse’s immune memory could be “boosted” by
multiple exposures to the same antigen, making future responses to it even more effective.
5.2.2 The programmed response
One of the implications of the programmed T cell response (described in Section 3.2.4) is
that the immune response is initiated by antigen but its outcome is antigen-independent.
If this is true, then removing antigen after the start of a response should not affect its
dynamics. This was tested in mice infected by L. monocytogenes (Mercado et al., 2000;
Badovinac et al., 2002). Antibiotics were administered to eliminate the infection 24 hours
after inoculation, which quickly removed all antigen. The peak of the T cell response
occurred at the same time in the antibiotic-treated mice and in non-treated control mice.
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Figure 5.7: Primary and secondary CTL responses to viral infection. The primary expo-
sure to the virus (•) is on day 0 and the secondary exposure at day 28. The number of T
cells ( ) speciﬁc to this virus includes na¨ ıve, effector, and memory cells.
The elimination of the infectious agent caused only a small reduction in the magnitude
of the response. Therefore, the elimination of antigen did not greatly affect the timing or
magnitude of the T cell response.
The model gives qualitatively similar results in a system using LCMV parameters (Fig-
ure 5.8). Since antibiotic effects are not immediate and do not directly remove bacteria in
mice infected with L. monocytogenes, I chose to eliminate all LCMV at 36 hours post-
infection instead of 24. Eliminating antigen caused the peak viral load of the response to
occur one day earlier and decrease only slightly in magnitude. The reduced response in
the model was due to the shortened recruitment time of na¨ ıve cells.
Incorporating the programmed response might be essential to modeling the efﬁcacy of
vaccinations. Vaccines often use attenuated strains of pathogens that have diminished or
no reproductive capacity and are rapidly cleared from the system. Since the purpose of
vaccination is to induce a large response in order to build a large pool of speciﬁc memory
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Figure 5.8: T cell response to an infection interrupted by treatment. The starting dose of
the antigen (•) was 10,000 virus particles. The antigen was removed from the system after
36 hours. The T cell response ( ) is not signiﬁcantly affected by the removal of antigen.
For simplicity, only a single T cell speciﬁcity and a single antigenic epitope were used.
The antigen and T cell levels of the control case, in which the antigen is not removed, are
plotted for comparison (dashed lines).
cells, thenalargedoseofanattenuatedvirusmightbeeffectiveevenifthevirusleveldrops
rapidly. If the T cell response were totally antigen-dependent, short periods of antigenic
stimulation would not stimulate an adequate response.
5.2.3 Na¨ ıve population size effects
The size of the initial na¨ ıve cell population can affect the outcome of an infection. Pre-
sumably, increasing the number of na¨ ıve cells can result in an earlier and larger response
to infection. This hypothesis was tested experimentally in mice (Ehl et al., 1998). The
number of na¨ ıve cells in mice was experimentally increased before infection in order to
determine how the number of responding na¨ ıve cells affects the T cell response to an
acute infection. It was estimated that about 50 na¨ ıve cells respond to LCMV in a normal
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Figure 5.9: The effect of increasing the number of na¨ ıve cells. One model run was initial-
ized with 50 na¨ ıve cells (△) and a viral load of 500 (◦). The other model run started with
50,000 na¨ ıve cells ( ) and the same initial virus load (•).
mouse (Ehl et al., 1998), and the number was raised to 50,000 by adoptive transfer from
donor mice. Increasing the number of na¨ ıve cells by 1000-fold moved the peak viral load
of the infection between 1 and 2 days earlier and reduced the viral load by about 2 logs.
In other words, the infection did not reach high levels. The model’s results are in agree-
ment with these experiments; after increasing the number of na¨ ıve cells from 50 to 50,000,
the peak virus load was one day earlier and about 2 logs smaller than in the control case
(Figure 5.9).
Surprisingly, the augmented immune response did not clear the infection more quickly
in the model. The virus’s reproductive rate is limited by the number of uninfected cells.
A virus that is too proliﬁc can exhaust the supply of new cells to infect. A weak immune
response might allow the virus to infect most healthy cells. Once this happens, the virus
is easier to eliminate because its spread is slowed. A stronger response might restrict viral
spread early enough so that a large pool of uninfected cells is maintained, so the virus is
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Figure 5.10: High- and low-avidity responses. The simulated viral load (•) is set to 500 on
day 0. The high-avidity clone ( ) peaks about two days earlier than the low-avidity clone
(△).
able to infect new cells as the response eliminates older infected cells. This effect can be
observed in Figure 5.9. Note that the decline of viral load is slower when it did not peak
at high levels.
5.2.4 High- and low-avidity responses
To study the clonal composition of the T cell response, I ran the model with a virus with a
single epitope and two T cell clones with different avidities to this epitope, a high-avidity
clone (K = 7.8×103) and a low-avidity one (K = 4.5×107). I assumed both clones
initially contained 50 na¨ ıve cells each. The peak of the high-avidity clone’s response is
over one log greater than and over one day earlier than the low-avidity one (Figure 5.10).
Scenarios involving larger numbers of clones are presented in the following section.
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5.3 The clonal composition of T cell responses
One of the strengths of the model is that it can create a large repertoire of CTLs with
different avidities to various antigens. Perhaps 20 T cell clones respond to a single epi-
tope (Maryanski et al., 1996; Blattman et al., 2002). These clones have afﬁnity not only
for the epitope in question, but for a range of related epitopes. In a system subjected to
heterologous infections, memory cells that cross-react to multiple antigens might be an
essential part of our immune responses (Welsh and Selin, 2002). For example, it has been
found that the CTL response to a particular hepatitis C epitope cross-reacts with an in-
ﬂuenza A epitope. Thus, one may gain partial protection from one pathogen by exposure
to an unrelated one. The digit string implementation, which implicitly deﬁnes an afﬁnity
between a TCR and any epitope, allows one to model the effect of heterologous infections
over an organism’s lifetime.
I simulated the response of a mouse with a realistic-sized repertoire to a viral infec-
tion. I used the xor distance rule (Appendix A.2) with an alphabet size of 128 and set
the MHC string length to be 4 digits and the peptide string length to be 6 digits. The
simulated mouse had 2.5×108 T cell speciﬁcities before thymic selection, but only about
200 of these were explicitly generated by the simulations, the remaining clones falling
outside the cross-reactive cutoff of the antigen. Of these, approximately 20–30 survived
the thymic selection process against 30,000 randomly generated self peptides to join the
na¨ ıve repertoire (Table 5.1).
5.3.1 The primary response
I simulated the primary CTL response to a viral infection. Early in infection, antigenic
levels were too low to stimulate T cell proliferation, so the na¨ ıve T cell population was
stable. As the virus infected cells, the higher-afﬁnity CTLs were stimulated and their
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Figure 5.11: Primary and secondary CTL responses to a viral infection. 500 viral units
were injected on days 0 and 28. The virus levels are indicated by • and the number of
CTLs in the three highest-afﬁnity clones as  , △, and ♦ (in decreasing order of afﬁnity).
Lower-afﬁnity clones are represented by lines with no markers. Each CTL clone initially
has 10 unstimulated na¨ ıve cells.
probability of entering the response increased. Low-afﬁnity CTLs were later stimulated
to join the immune response when antigen reached sufﬁciently high levels (Fig. 5.11).
Thus, the entry of clones into the response was staggered, with progressively lower afﬁnity
clones tending to enter the response later. A similar observation has been made in murine
systems: the contribution of a T cell clone to an immune response is largely determined by
the time of its entry into the response (Bousso et al., 1999). Low-afﬁnity clones sometimes
responded more quickly than high-afﬁnity ones because the simulation is stochastic. With
a more slowly growing virus, this occurred less often because the more gradual rise in
antigen levels led to a greater delay between the times of stimulation of high- and low-
afﬁnity T cells (data not shown).
Even among syngeneic mice, the CTLs involved in a primary response can have a
variable mix of afﬁnities for antigen (Bousso et al., 2000). Similarly, different runs of
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the model with identical initial parameters had different responding clones. Because the
initial number of cells in a single clone is small, stochastic effects play a large role in the
composition of the primary response. In the model, a newly stimulated na¨ ıve T cell must
survive a high death rate between the time of antigenic stimulation and the beginning of its
programmed response, so that on average only 6 cells out of the 10 from a particular T cell
clone survive to proliferate. Because the model is discrete and assumes that proliferation
is antigen-independent, a response that begins with 1 to 6 proliferating cells will peak
between 60,000 and 360,000 effector cells. This agrees with the estimate that only 1
to 6 cells per clone initiate CTL responses in mice and that individual clones produce
between 4×104 and 3.7×105 cells at the peak of the response (Bousso et al., 1999). As
a consequence of the antigen-independent proliferation of CTLs, memory levels formed
by the primary response in the model are proportional to the initial number of cells that
successfully enter proliferation because a constant fraction of effector cells formed convert
to memory (about 5%).
The average afﬁnity of T cells changed dramatically during the response to infection in
the model. I deﬁne the average afﬁnity of the response to be the inverse of the average Kd
value (deﬁned in Section 4.4) of all CTLs. Three days after infection, the average afﬁnity
rose (i.e., the average Kd fell) rapidly as high-afﬁnity clones expanded (Fig. 5.12). The
rising antigen levels progressively crossed the stimulation threshold of lower and lower
afﬁnity cells and recruited them into the response. As the T cell response peaked, the aver-
age afﬁnity dropped (i.e., Kd rose) as the contribution of low-afﬁnity clones to the overall
response increased and the programmed expansion of high-afﬁnity cells ended. The aver-
age afﬁnity stabilized after day 10 as memory cells formed and dominated the population.
These trends agree with observations made during experimental infection of mice with
paramyxovirus simian virus 5: high-afﬁnity CD8+ T cell clones were exclusively detected
early in the CTL response at day 3, but low-afﬁnity clones comprised ∼50% of the re-
sponse by day 5 post-infection (Gray et al., 2003). Similarly in the model, low-afﬁnity
clones comprised half of the response after day 7 post-infection. I also measured the
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Figure 5.12: The average CTL afﬁnity during primary and secondary responses to antigen.
Afﬁnity is 1 divided by the dissociation constant Kd, which is deﬁned as the amount of
antigenrequiredtoinducehalf-maximalstimulationinaCTL.500viralunitswereinjected
on days 0 and 28. The data plotted are the average values from 100 experiments.
afﬁnity of the response as the ratio of low-afﬁnity CTLs to high-afﬁnity CTLs. This ra-
tio rapidly dropped at the beginning of the CTL response then rose after day 7 (Fig. 5.13),
which agrees qualitatively with observations in mice following infection with recombinant
vaccinia expressing a well-characterized peptide antigen from ovalbumin: this ratio was
initially high, dropped by day 6 post-infection, and returned to a high value in the memory
population after the primary response (Alexander-Miller, 2000).
5.3.2 The secondary response
I simulated a secondary response to antigen by injecting additional virus into the system
28 days after a primary challenge. The T cell clonal hierarchy in the secondary response
was more consistent across different simulation runs than that observed in the primary
response. In the simulations of the secondary response to virus, I found that the same
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Figure 5.13: The ratio of low- to high-afﬁnity T cells during a primary and secondary
response to antigen. 500 viral units were injected on days 0 and 28. The data plotted are
the ratios of the number of cells of the 26 lower-afﬁnity clones to the 3 highest-afﬁnity
clones averaged over 100 experiments.
highest-afﬁnity T cell clones were dominant, while a variable mix of lower-afﬁnity clones
comprised a small fraction of the response. The recruitment of high-afﬁnity memory cells
drove a second increase in average T cell afﬁnity for antigen (Fig. 5.12).
The model results agree with observations that the clonal composition of the secondary
response in mice varies less than the primary among syngeneic animals (Bousso et al.,
2000; Bachmann et al., 1997; Busch et al., 1998a; Blattman et al., 2000; Kedzierska et al.,
2004), that the secondary response is composed of a smaller set of responding
clones (Savage et al., 1999), and that while the primary response recruits a mix of
high- and moderate-afﬁnity clones, the secondary preferentially recruits high-afﬁnity
clones (Estcourt et al., 2002). In the simulations, this consistency of the secondary re-
sponse compared to the primary occurs because of the larger number of cells involved. As
discussed above, precursor frequencies are low in the primary response, allowing stochas-
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(a) (b)
Figure 5.14: CTL responses to non-replicating virus followed by replicating virus chal-
lenge. The non-replicating virus dose on day 0 was (a) 2×106 units and (b) 4×104 units.
The replicating virus challenge of 5,000 viral units was administered on day 28 in both
experiments. Virus levels are indicated by • and the number of CTLs in the three highest-
afﬁnity clones as  , △, and ♦ (in decreasing order of afﬁnity). Lower afﬁnity clones are
represented by lines with no markers.
tic effects to determine whether the ﬁrst cell to proliferate will come from a high- or
low-afﬁnity clone. By contrast, there is a large number of cells per clone in the secondary
response, and the hierarchy of responding cells is therefore much more stable among sim-
ulation runs.
5.3.3 Non-replicating antigen
I simulated immunization with 2×106 viral units of non-replicating antigen. This immu-
nization created a sharp spike in the antigen level that rapidly decayed. The high initial
antigen load maximally stimulated all T cells with an afﬁnity above a certain threshold
(dependent on the antigen dose). This is in contrast to infection with replicating antigen,
in which the gradually increasing antigen stimulates high-afﬁnity clones ﬁrst and gives
them a time advantage over the lower-afﬁnity clones. If these high-afﬁnity clones clear
the infection quickly, then low-afﬁnity clones receive insufﬁcient antigenic stimulation to
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be recruited into the response. This time advantage is not a factor in infection with non-
replicating antigen, in which the sharp spike in antigenic stimulation caused clones of dif-
ferent afﬁnities to peak simultaneously (Fig. 5.14a). Because the model features antigen-
independent proliferation, the high-afﬁnity clones do not interfere with the proliferation of
low-afﬁnity clones that have already been stimulated. Therefore, non-replicating antigen
creates a ﬂatter distribution of high- and low-afﬁnity clones, with the average afﬁnity being
dependent on the antigen dose. The decay phase of antigen provides a period during which
high- and low-afﬁnity clones receive different degrees of stimulation. That is, as antigen
levels progressively decline, only high-afﬁnity cells are stimulated. This occurs for both
replicating and non-replicating antigen, as both undergo a decay phase. However, this
effect probably makes only a small contribution to differentiating high- and low-afﬁnity
cells for two reasons: (i) it might occur during the phase of antigen-independent prolifer-
ation, and (ii) if antigen decay is very rapid, there is little time difference between when
the stimulation thresholds of high- and low-afﬁnity cells are crossed.
A variety of experiments suggests that a higher-afﬁnity response can be recruited with
lower doses of antigen (Rees et al., 1999; Alexander-Miller, 2000; Walter et al., 2003).
Presumably, low doses of antigen cannot stimulate low-afﬁnity clones, but can stimu-
late high-afﬁnity ones. These high-afﬁnity clones appear to be better for infection con-
trol (Alexander-Miller et al., 1996; Derby et al., 2001). To investigate this phenomenon, I
simulated inoculation with a smaller dose of 4×104 viral units of non-replicating antigen.
Fewer clones responded to the low dose (Fig. 5.14b) than the high dose (Fig. 5.14a). The
low dose produced memory cells with a higher average afﬁnity for antigen than the high
dose. However, because the low dose recruited small numbers of T cells, systematic dif-
ferences in afﬁnities recruited by the different antigen doses were sometimes obscured by
stochastic effects. When used as a vaccine, the smaller antigen dose afforded less protec-
tion against subsequent infection by virus, allowing the virus to peak at levels three times
higher than in the trial with the larger antigen dose. The large number of memory cells
of various afﬁnities formed in response to the high-dose vaccine provided better protec-
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Figure 5.15: Comparison of responses to replicating and non-replicating virus challenges.
For the replicating virus infection, the virus levels are indicated by • and the total number
of CTLs by  . For the non-replicating antigen, the antigen levels are indicated by ◦ and
the total number of responding CTLs by △. The data in this ﬁgure are drawn from the
experiments shown in Figs 5.11 and 5.14b.
tion than the small number of high-afﬁnity cells from the low-dose vaccine. The lack of
increased protection using low doses might be because the simulation does not include
direct competition between clones. Thus, the same set of high-afﬁnity clones are stimu-
lated with high- and low-dose antigens in the simulation and grow equally well, while in
an animal vaccinated with a low dose, these high-afﬁnity clones may expand more due to
a lack of competition with low-afﬁnity clones for resources.
Comparing the dynamics of the CTL responses to replicating and non-replicating virus
infection yielded results similar to those found in mice responding to a killed bacteria
vaccine (Lefranc ¸ois et al., 2003). In both the computer model and the mouse experiments,
theCTLlevelsinthereplicatingandnon-replicatingvirusscenarioswereindistinguishable
on day 5 (Fig. 5.15). However, the responses soon diverged, with the response to the
replicating virus peaking days later while the response to the non-replicating declined.
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number of clones distance to self peptide
resolved unres. p-value resolved unres. p-value
Hamming 27.13 24.57 5.07×10−10 18.93 19.12 2.63×10−2
xor 23.97 21.18 2.20×10−16 76.75 69.36 2.82×10−16
L1′ 29.16 25.36 2.20×10−16 9.76 8.50 2.20×10−16
Table 5.3: Differences between repertoires that cleared infection and those that did not.
For each of the metrics, the CTL simulation was run 1,000 times, and the infection was
considered to be resolved if there was no virus present four weeks after infection. The
second and third columns show the average number of CTL clones instantiated per epitope
in the resolved and unresolved cases. The ﬁfth and sixth columns show the antigenic
distance between the epitope and the nearest self peptide in the resolved and unresolved
cases. The p-values are from two-sample t-tests.
The ﬁnal memory cell level induced by the replicating virus infection was about an order
of magnitude larger than that from the non-replicating antigen.
5.3.4 The number of CTL clones per epitope
The CTL response does not always resolve infections in the model. Because the na¨ ıve
repertoires are generated stochastically, some are more capable of eliminating particular
antigens than others. I compared the repertoires that were able to clear an infection and
those that could not. I ran the simulation 1,000 times for each of the three distance met-
rics (Hamming, xor, and L1′) using an initial virus dose of 1,000. The virus dynamics
parameters are from Table 5.2, and infected cells express a single epitope. I considered the
infection to be resolved if there was no virus present four weeks after infection. For the
Hamming distance trials, 80% of the infections were resolved. For the xor and L1′ trials,
61% and 69% were resolved, respectively. The differences in these rates is not a property
of the metrics themselves, but reﬂect the difﬁculty of calibrating the different metrics to
produce similar results.
For each epitope instantiated during a simulation, a set of na¨ ıve CTL clones is created
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using lazy evaluation (Section 4.2.2). All of these clones have some afﬁnity for infected
cells expressing this epitope, although not all of them participate in the response because
of stochastic effects and indirect competition among clones for antigen. A higher num-
ber of instantiated clones correlates with a higher probability of pathogen clearance in the
model. For all three distance metrics, the average number of clones instantiated was higher
for cases in which the antigen was cleared than in those in which it was not (Table 5.3).
Somewhat surprisingly, the antigenic distance from the epitope to the nearest self peptide
also had an effect for two of the three distance metrics. The average distance was higher in
the resolved cases for the xor and L1′ trials (Table 5.3). It appears that this is because the
less similar an epitope is from all self peptides, the larger the number of clones generated
for that epitope by the simulation for the xor and L1′ cases (Figure 5.16). This is probably
because negative selection eliminates pre-selection CTLs that are too “close” to self pep-
tides. For Hamming distance, the distance between the epitope and the nearest self peptide
did not correlate with either the resolution of infection (Table 5.3) or the number of CTL
clones instantiated (Figure 5.16a). These results are consistent with those in Section 5.1.5,
in which the Hamming distance between an epitope and the nearest self peptide had no
effect on CTL peptide binding degeneracy.
5.4 Summary
In this chapter, I tested the CTL model described in Chapter 3 under a wide range of
conditions. Most of the model’s results agree with the experimental literature, and the
model makes a large number of predictions for laboratory experiments that have not yet
been performed. Some of the results probe the composition of the na¨ ıve CTL repertoire
and its ability to detect antigen. The remaining results explore the dynamics and efﬁcacy
of the CTL response.
The results of my model reveals effects of thymic selection that are different than pre-
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(a) Hamming (b) xor
(c) Manhattan
Figure 5.16: Number of clones vs. distance between an epitope and its closest self pep-
tide. 10,000 random epitopes were generated, and the distances between these epitopes
and their nearest self peptides were measured. A new CTL repertoire was created for each
of these epitopes, and the average and standard deviation of the number of CTL clones is
plotted against the epitope to selecting peptide distance. The results shown are from sim-
ulations using three distance metrics: (a) Hamming, (b) xor, and (c) modiﬁed Manhattan
distances.
viously believed. The standard view of immunologists is that the role of negative selection
in the thymus is to eliminate CTLs that respond to self peptides and the role of positive
selection is to eliminate CTLs that can not bind MHC. The results from the model reveal
more complex effects. Because TCRs bind to both peptide and MHC, negative selection
also affects the CTL repertoire’s afﬁnity for MHC and positive selection affects its afﬁnity
for self peptide. In the model, negative selection eliminates both CTLs that are have high
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afﬁnity for self peptides and those that have high afﬁnity for MHC. Positive selection not
only eliminates CTLs that have low afﬁnity for MHC, but also those with low afﬁnity for
all self peptides. I have found evidence of these effects in the literature. An implication of
these ﬁndings is that thymic selection does not only eliminate CTLs that would be detri-
mental or useless in an immune response, but those that are inefﬁcient and suboptimal.
Thus, the process of thymic selection can be cast as an optimization problem.
The dynamic behavior of the model reproduces many observations of CTL responses
in mice. In normal infections, the secondary response is larger and faster than the primary
because of the larger pool of CTL and the shorter delay in the response of memory cells.
One consequence of the greater magnitude of secondary responses is that they are more
consistent among identical individuals than the primary response. The immune system
can be manipulated in the laboratory to produce different behaviors. For example, antigen
can be eliminated by massive doses of antibiotics or the immune response can be boosted
by injecting extra T cells. The behavior of the model agrees with real-world experiments
in these situations, and this agreement indicates that the model could be used to predict
the outcome of similar laboratory experiments. One surprising result is that the immune
response could clear an infection that reaches high viral loads faster than an infection that
does not reach high levels. When a virus is too successful and infects most of the body’s
cells, the immune system can eliminate it quickly. If the infection is less extensive, then
the infection is prolonged because the virus spreads to uninfected cells even as the im-
mune system is eliminating infected cells. Thus, it is possible that a less effective immune
response could result in a better outcome for the organism.
Other beneﬁts of using a computer model instead of mouse models include the abil-
ity to make extremely detailed observations and to reproduce experiments exactly. For
example, the afﬁnity of responding cells may determine the body’s ability to eliminate
an infection, and the model makes predictions about the composition of the response that
are supported by real-world observations. Low doses of vaccine recruit only the highest-
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afﬁnity CTLs, while high doses recruit a broad range of afﬁnities.
Three versions of the model, each using a different deﬁnition of antigenic distance,
were tested. The versions using xor and modiﬁed Manhattan distance produced results
consistent with each other, while the Hamming distance version yielded different results
in Sections 5.1.5 and 5.3.4. Hamming distance might be fundamentally different than the
other two distance metrics, or these discrepancies could simply be due to the choice of
parameters used in the models. It is not surprising that the xor and modiﬁed Manhattan
distance versions agreed—they produce similar afﬁnity distributions in the model (Sec-
tion 4.4). The Hamming metric differs because it is coarse—the distance between digits
is either 0 or 1, while the distance between digits in the other two metrics covers a range
of values. This makes it difﬁcult to calibrate the Hamming version of the model to match
the others. It is possible that the differences in the metrics would disappear if longer string
lengths were used to represent the TCRs and the peptides, but the number of possible pep-
tides and TCRs would be unrealistically large and the model would be difﬁcult to run. For
reasonable string lengths, these differences will undoubtedly affect the model’s results.
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Immune exhaustion and mutating
pathogens §
La perfection est atteinte non quand il ne reste rien ` a ajouter, mais quand il
ne reste rien ` a enlever.
[You know you’ve achieved perfection in design, not when you have nothing
more to add, but when you have nothing more to take away.]
—Antoine de Saint Exupery
So little of what could happen does happen.
—Salvador Dal´ ı
The model presented in Chapter 3 used to produce the results in Chapter 5 assumes that
viral infections are resolved quickly. When the immune system can not clear an infection
quickly or if the body is repeatedly exposed to antigens, CTLs can behave differently.
During long-term infections, CTLs can die from over-stimulation, a phenomenon known
as exhaustion. To explore long-term dynamics in the model, I added exhaustion to the
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model (Section 6.1). Without this feature, the model can produce unrealistically large
primary responses to antigens, and this effect is compounded if the infection is not cleared
by the primary response, leading to wild oscillations in CTL and virus levels. Adding
exhaustion to the model not only affects the ability of the immune system to clear an
infection (described in Section 6.2), but it also allows one to observe a response that lasts
for longer periods of simulated time. As an illustration of a prolonged CTL response, I
record the effects of a rapidly mutating virus in Section 6.3.
The results described in this chapter should be interpreted with caution. Experimen-
talists have studied acute responses more thoroughly than the long-term dynamics of the
immune system. This is due, in part, to their reliance on mouse models. Not only do
mice have short life spans, but immunological assays often require the mouse to be killed.
Instead of tracking individual mice over time in longitudinal studies, researchers usually
begin with a cohort of identical mice and sacriﬁce them at different times to simulate a
time series. This approach is problematic if the mice are not identical or if stochastic
effects play a signiﬁcant role in the immune response.
Long-term dynamics are also difﬁcult for modelers. For some infections, one can
assume that the CTL response is so fast and effective that the contribution of other com-
ponents of the immune system is minor. However, if the infection is not resolved quickly,
then the roles of other immune cells, such as helper T cells, B cells, and macrophages,
cannot be ignored. Therefore, realistic models of long-term infections need to be consid-
erably more complex. The mechanism for immune exhaustion proposed in this chapter is
intended to be biologically plausible but not complete.
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6.1 Implementation
When over-stimulated by antigen, CTLs can become anergic or even die, a phe-
nomenon known as exhaustion. Prolonged exposure to antigen appears to cause effec-
tor CTLs to become progressively more impaired, eventually leading to T cell dele-
tion (Fuller and Zajac, 2003; Wherry et al., 2003). High doses of antigen or moderate
doses of antigens that express excessively high epitope levels can also induce apoptosis in
CTLs (Moskophidis et al., 1993; Wherry et al., 1999, 2002). Exhaustion might be a pe-
ripheral tolerance mechanism to eliminate self-reactive T cells. If thymic selection does
not eliminate all T cells that react to healthy cells (i.e., central tolerance fails), then these
cells will react to the extremely high constant levels of self peptides in the body. Exhaus-
tion might prevent self-reactive T cells from effecting a sustained response against healthy
tissue (Anderton et al., 2001).
I assume that exhaustion is induced by antigenic stimulation because high-afﬁnity T
cells are preferentially eliminated by high doses of antigen (Anderton et al., 2001) and
those that respond to immunodominant epitopes appear to be more susceptible to exhaus-
tion than those that respond to subdominant epitopes (Aichele et al., 1997; Zajac et al.,
1998; Slifka et al., 2003). It has also been found that death of effector T cells by antigenic
stimulation in vitro is dose-dependent (Iezzi et al., 1998).
To add CTL exhaustion to the model, I introduce an additional effector cell death term
based on the level of antigenic stimulation that it receives. Recall that stimulation was
deﬁned in Equation 3.13:
Stimulation =
å
eiIi
Ki
1+å
eiIi
Ki
(6.1)
Stimulation determines the rate at which na¨ ıve and memory cells are recruited into the
response. If this level of exposure to antigen recruits cells, then I assume that a higher
level will cause these cells to die. Therefore, I introduce a new term, “over-stimulation,”
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which is identical to stimulation except that the dissociation constants K are multiplied by
25:
Over-stimulation =
å
eiIi
25Ki
1+å
eiIi
25Ki
(6.2)
Like the original stimulation term, over-stimulation is a function that saturates at high
levelsofantigen, exceptthatitrequireshigherlevelsofantigenforittoreachitsmaximum.
In addition to their normal death rates, effector CTLs are also subjected to a death rate of
ds = 5 day−1 times the “over-stimulation.” This rate needs to be high to counter the high
proliferation rate of effector CTLs.
Overexposure to antigen also appears to impair the formation of immunological mem-
ory. Memory T cells formed during a persistent infection can be unresponsive to anti-
gen (Masopust et al., 2004; Wherry and Ahmed, 2004). Therefore, the effector cells that
are in the process of converting to a memory phenotype die at a rate of the stimulation (not
the over-stimulation) times 1.0 day−1. The effector cells at the end of their programmed
division cycles (see Section 3.2.4) also die at this rate.
In summary, na¨ ıve CTLs convert to effector cells upon exposure to antigen. If effector
cells are exposed to levels of antigen much higher than that necessary to recruit them, they
die of over-stimulation. If there is antigen present at the end of the primary response, most
effectors die without converting to memory cells.
6.2 Viral dynamics and viral clearance
It has been observed that LCMV infection (see Section 2.1.4) is more likely to be
chronic if the virus is administered at high doses or if a more virulent strain is
used (Moskophidis et al., 1993). I used the model to simulate infections with slow- and
fast-replicating viruses administered at low (500 units) and high (10,000,000 units) doses.
For the slow-replicating virus, I set p = 65 and b = 1×10−7 and for the fast-replicating
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virus, I set p = 100 and b = 2×10−7. Section 3.1 deﬁnes these parameters. Typical runs
are shown in Figure 6.1. In many cases, the initial CTL response does not resolve the
infection. When the primary response fails to eliminate the virus, the viral load rebounds,
and the memory cells formed by the ﬁrst effector CTLs eliminate the virus a few weeks
later in a secondary response (e.g., Figures 6.1c and d).
For the slow-replicating virus, the immune system could clear the infection more easily
for low- than high-dose exposures (Table 6.1). For the fast-replicating virus, the immune
system could rarely clear the infection quickly, regardless of the initial dose (Table 6.1).
These results are qualitatively consistent with LCMV observations. However, the dynam-
ics of a prolonged infection do not agree with laboratory observations.
In the lab, a persistent virus can survive at low levels in an apparent dynamic equilib-
rium with the immune response. In the model, viral replication and CTL clearance never
ﬁnd an equilibrium value, and the viral load declines during a CTL response and rapidly
recovers when the programmed response ends. Additions to the model could allow the
virus to persist at low levels. One extension would be the introduction of spatial com-
partments to the model. In the current model, the immune cells are assumed to be evenly
mixed throughout the body, so the entire body is under the same level of immune surveil-
lance. If the body in the model were compartmentalized, then spatial heterogeneity would
give the virus the ability to temporarily evade the immune response by moving to new
compartments. The virus might be able to survive at low levels under these circumstances.
Adding complexity to the CTL response would also change the kinetics of viral clearance.
The model assumes that an effector CTL will eliminate infected cells at the maximum rate
until its programmed response ends or the cell is killed by exhaustion. In fact, real effector
cells gradually lose effector functions (Fuller and Zajac, 2003; Wherry et al., 2003), and
they can even recover functions after losing them (Schwartz, 2003). Adding a wider range
of CTL response levels to the model could allow the virus to persist at an equilibrium level.
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Figure 6.1: The resolution of infection with slow- and fast-replicating virus strains in-
troduced at low and high doses. The low dose was 500 viral units, and the high dose
was 10,000,000. The plots show representative runs initialized with (a) low-dose of slow-
replicating virus, (b) high-dose of slow-replicating virus, (c) low-dose of fast-replicating
virus, and (d) high-dose of fast-replicating virus. The virus loads are indicated by lines
marked by • and the numbers of CTLs from each clone are plotted as unmarked lines.
6.3 Immune escape
Some antigens can alter their epitopes in order to evade the immune response. If the
immune response targets a particular immunodominant epitope, infected cells expressing
variants of this epitope might partially or fully avoid detection by effector cells. The
immune system subjects pathogens to evolutionary pressure. Rapidly mutating pathogens
can generate thousands of new antigenic strains within a single host, and the successful
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slow fast
low-dose high-dose low-dose high-dose
Hamming 99% 99% 2% 8%
xor 41% 20% 0% 0%
L1′ 64% 52% 1% 0%
Table 6.1: The resolution of infection with slow- and fast-replicating virus strains intro-
duced at low and high doses. The low dose was 500 virus particles, and the high dose
was 10,000,000 virus particles. For each set of parameters, the CTL simulation was run
100 times, and the numbers in the table indicate the percentage of these runs in which the
infection was resolved, which I deﬁne to be the absence of virus four weeks after infection.
mutants can quickly spread, while the unsuccessful ones disappear. The immune system
is also highly adaptable, and the host and pathogen must compete for control of the body.
I ran simulations with mutating pathogens that express a single epitope and have the
same growth parameters as the slow-replicating virus described in Section 6.2. The non-
mutating version of this virus, when administered at low doses, could usually be cleared
within four weeks (Table 6.1). By adding a mutation rate of 10−5 mutations per virus
replication (mutation is deﬁned in Section 4.3), the infection was rarely cleared. Mutant
strains are assigned the same replication and mutation rates as their parent strains. The
total virus loads oscillated, peaking about every two weeks. Typical runs are shown in
Figure 6.2.
The progression of individual virus strains is plotted in Figure 6.3. The dark vertical
bands in these plots correspond to the simultaneous peaks of multiple strains. The strains
that comprise each peak are not necessarily created at the same time; one can see that the
lines that represent each strain can begin at different time points but still peak at the same
time. Therefore, I assume that the CTL response periodically suppresses the spread of
most strains, which proliferate after the response diminishes. Most strains do not survive
these purges. The peaks in the viral loads are followed by bursts of new mutants, which
appear in in Figure 6.3. as groups horizontal lines that start at the same point on the x axis.
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(a) Hamming (b) xor
(c) Manhattan
Figure 6.2: The viral load of a slowly mutating pathogen. The mutation rate of the virus is
1 mutation for every 105 replications. Solid lines represent CTL levels, while the dashed
lines represent the total viral load of all strains. Versions of the model using different deﬁ-
nitions of antigenic distance were used: (a) Hamming, (b) xor, and (c) modiﬁed Manhattan
distance.
From these observations, I assume that the original virus replicates until it reaches high
levels and generates variants. The CTL response eliminates the original strain and most
of its descendents, but some of the strains will survive, possibly because their epitopes
escape immune system detection or possibly just by luck. The growth of these survivors
is temporarily suppressed by the cross-reactive CTL response, which eliminates cells in-
fected with the original virus and similar strains. Because the programmed response of
effector cells lasts for only a few days, each response will eventually end. When the initial
response is over, the surviving strains soon generate a second peak in viral load, which
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Figure 6.3: Emergence of strains using slowly mutating pathogens. The individual strains
are displayed from the same trials shown in Figure 6.2. The virus load of each distinct
strain over a period of sixty days is represented as a row of gray dots, and the darkness of
each dot is proportional to the log of the viral load of that strain at a time point. Time runs
along the x-axis. Versions of the model using different deﬁnitions of antigenic distance
were used: (a) Hamming, (b) xor, and (c) modiﬁed Manhattan distance.
recruits a new set of CTLs. A new set of strains is created during this peak.
The viral load peaks of multiple strains do not remain synchronized. If a new mu-
tant virus has an epitope that is not recognized by effector CTLs, then it can replicate
before the response to its parental strain is over. This can be observed when the mutation
rate was raised to 10−4 mutations per virus replication. Figure 6.4 plots the total virus
loads of representative runs, and Figure 6.5 shows the progress of the individual strains in
these runs. Although the viral load peaks are synchronized at ﬁrst, they quickly go out of
phase and the peaks become less coherent over time (Figure 6.4). The faster mutation rate
quickly generates mutants that express epitopes that evade the immune response. The re-
sponses to these different strains is independent, thus their dynamics are not synchronized
by cross-reactive CTL responses. This effect is less apparent when Hamming distance is
used to deﬁne antigenic distance (Figures 6.4a and 6.5a). The viral loads of the various
strains appear to remain synchronized. In the Hamming distance version of the model, a
single mutation in an epitope never allows a virus to escape CTL detection (Section 4.3).
Therefore, the cross-reactive CTL response can keep a strain and its mutants synchronized,
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Figure 6.4: The viral load of a quickly mutating pathogen. The mutation rate of the virus
is 10−4 mutations per replication. Solid lines represent CTL levels, while the dashed lines
represent the total viral load of all strains. Versions of the model using different deﬁni-
tions of antigenic distance were used: (a) Hamming, (b) xor, and (c) modiﬁed Manhattan
distance.
perhaps until strains accumulate multiple mutations.
The mutation rate does not signiﬁcantly affect the rate at which virus strains can accu-
mulate mutations. It is unlikely that a virus will produce a mutant strain until it reaches
high population levels, at which point it can produce many new strains that differ from
itself by exactly one mutation. The CTL response to the parent strain keeps these new
viruses at low levels or eliminates them altogether. Therefore, these new strains will not
replicate widely enough to generate their own mutant strains (which would differ from the
parent by two mutations) until the previous CTL response diminishes. Thus, the number
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Figure 6.5: Emergence of strains using quickly mutating pathogens. The individual strains
are displayed from the trials shown in Figure 6.4, Each distinct strain is represented as a
row of gray dots, and the darkness of the dot is proportional to the log of the viral load of
that strain at a time point. Time runs along the x-axis. Versions using three different deﬁ-
nitions of antigenic distance were used: (a) Hamming, (b) xor, and (c) modiﬁed Manhattan
distance.
of mutations that can accumulate within a single lineage is limited to approximately one
mutation every two weeks, regardless of the virus’s mutation rate.
Many pathogens produce periodic “bursts” of new strains in their hosts. Some
examples (many of which are reviewed in Deitsch et al. (1997)) are Plasmodium fal-
ciparum (which causes malaria) (Roberts et al., 1992), Trypanosoma brucei (sleep-
ing sickness) (Barry, 1986; Vickerman, 1989), and Anaplasma marginale (rick-
ettsemia) (French et al., 1999). Although some of these pathogens are controlled by the B
cell response, the primary mechanisms that create the viral load oscillations in my T cell
model (i.e., cross-reactivity and a delayed immune response) also apply to other forms
of immune response. This phenomenon has been modeled by others (e.g., Nowak et al.
(1995); Antia et al. (1996); Haraguchi and Sasaki (1997); Recker et al. (2004)). These
models include separate “strain-speciﬁc” responses that can eliminate only a particular
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antigenic strain and “cross-reactive” responses that are effective against all variants. In
my model, these “responses” are not separate. The CTLs in my model eliminate infected
cells at a rate based on the similarity between their receptors and the MHC–epitope com-
plex. My CTL model also differs from previous work by including a programmed CTL
response. The programmed response causes the frequency of oscillations in viral load to
be determined solely by CTL kinetics, not viral kinetics. The result is that the period be-
tween peaks in viral load are the same for any virus, regardless of its replication rate. Data
in the literature to support or contradict this result is difﬁcult to ﬁnd because the patho-
gens that produce periodic peaks are generally parasites, not viruses, so they will not be
controlled by CTLs.
6.4 Summary
I added immune exhaustion to the CTL model by incorporating an additional effector cell
death term. With this extended model, I found that increasing the initial dose or the growth
rate of a virus makes it more difﬁcult for the immune system to eliminate it. Adding
exhaustion also made the model’s prolonged CTL responses more realistic, so I tested the
effects of infecting the system with a mutating pathogen. The virus level oscillated, with
peaks about every two weeks. These oscillations were caused by the regular creation of
new viral strains and their elimination by CTLs. A higher mutation rate decreased the
coherence of these oscillations but did not increase the rate at which a single strain could
accumulate mutations over time. The model’s response to a mutating pathogen highlighted
another difference among the different distance metrics. The CTL response was highly
cross-reactive when the Hamming distance metric was used, so the CTL responses to
various mutant strains remained synchronized. For the other metrics were used, a single
mutation could sometimes cause a new variant to temporarily evade the CTL response.
The set of na¨ ıve CTLs responding to this variant would behave independently of the CTLs
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responding to the parent strain, so the oscillations in total viral load become less well-
deﬁned over time.
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Conclusion §
I had worked hard for nearly two years, for the sole purpose of infusing life
into an inanimate body. For this I had deprived myself of rest and health. I
had desired it with an ardour that far exceeded moderation; but now that I had
ﬁnished, the beauty of the dream vanished, and breathless horror and disgust
ﬁlled my heart...
—Mary Shelley, Frankenstein
I developed a computer model of the cytotoxic T lymphocyte (CTL) response to viral
infection. Usingthismodel, Iexploredthecompositionofthena¨ ıveCTLrepertoireandthe
dynamics of the CTL response. The model revealed a mechanism by which the immune
system can shape the na¨ ıve CTL repertoire to detect foreign peptides with efﬁciency using
positiveandnegativeselection. Thismechanismisbothbiologicallyplausibleandexplains
several somewhat surprising results in the literature. Further experiments are necessary to
reﬁne the hypothesis. If the model’s results prove to be correct, then the model could be
used to develop “thymic vaccination” therapies, in which peptides are introduced directly
into the thymus to shape the immune cell repertoire (Fridkis-Hareli et al., 2004).
The model also replicates the dynamics of the CTL response to viral infection under a
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wide variety of conditions, including natural infection, vaccination with a non-replicating
antigen, administration of antibiotics, and the injection of massive amounts of additional
CTLs. The typical approach to immunological modeling has been to create a minimal
model for each of these scenarios, which makes the models easier to construct but re-
stricted in scope. By creating a single model that accommodates many different immuno-
logical phenomena, one can use it to test new combinations of vaccination and other treat-
ment strategies for preventing or controlling viral infection.
I have demonstrated that modeling can be used to enhance our understanding of im-
munology in different ways. Some of the results described in this work took advantage of
the ease with which one can perform experiments with a computer model. For example,
Section 5.1’s analysis of the CTL repertoire before and after thymic selection would be
extremely expensive and time-consuming to perform in the laboratory. Computer models
can be used to run experiments before more costly animal tests are used. I performed
other experiments in an attempt to explain known CTL behavior. Although the model con-
tains a simple representation of the CTL life cycle, the magnitude and composition of the
simulated responses reported in Sections 5.2 and 5.3 resemble those observed in mouse
experiments. Thus, the elements of CTL behavior included in the model could be the
primary factors governing short-term responses. In Chapter 6, I use the model to explore
immunological phenomena that are not well-understood. Because models can be easily
modiﬁed, they provide convenient vehicles for hypothesis testing.
A major task in constructing the model was the representation and implementation of
CTL–infected cell binding. Because it was infeasible to implement a simulation of the
molecular binding interactions between a TCR and an MHC–peptide complex, I used a
highly abstract digit string representation for the TCR and the complex and a string dis-
tance rule to deﬁne the binding strength between them. The distance calculation had to be
computationally efﬁcient but still capture some aspect of the binding interactions. Because
there is no single “correct” rule for this purpose, I implemented three different ones and
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ran the model using each of them. When there is only one epitope in the system, then
the choice of rule is less important—all three distance rules that I used produced similar
afﬁnity distributions. In experiments involving only a single epitope, I arbitrarily chose
to use the xor metric, which was the most efﬁciently implemented. When studying the
foreign peptide coverage of a CTL repertoire or simulating exposure to mutating antigens
or more than one kind of pathogen, the choice of distance metric becomes important; the
metric deﬁnes how cross-reactive responses behave in the model, which play a major role
in these situations. I assumed that a result produced by all three versions of the model was
robust to the metric’s deﬁnition. If an effect only occurred using one of the metrics, then
I had less conﬁdence in the result. In such cases, one needs to consider why an effect de-
pends on the deﬁnition of the metric and what properties do the molecular binding events
that occur in the immune system share with the metric. Each metric probably has unique
characteristics that reﬂect some of the properties of the “real” binding events that occur in
the body, so each could be valid in different situations.
Model-building requires one to make many simpliﬁcations, assumptions, and compro-
mises. By necessity, a model is a simpliﬁed representation of the system of interest. The
simpliﬁcation process demands that many aspects of the system be ignored or drastically
reduced. Some of the decisions I made while implementing the model were based com-
putational efﬁciency rather than biological ﬁdelity. For example, because little is known
about how the birth and death rates of effector CTLs change during the course of a re-
sponse, I assumed that they were constant. Such assumptions made both the implemen-
tation and calibration of the model easier. As more quantitative measurements are made
of the CTL response to antigen, the model should be extended to include them. I chose
to adapt the scope of my model to match data available in the literature. However, the
literature grows each day, and our ability to observe immune cells is improving so rapidly
that many parts of the model will require revision within a few years. In particular, quanti-
fying the effects of interactions among different kinds of immune cells, such as the innate
immune system and helper T cells, will provide modelers with new opportunities. These
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interactions will advance the state of immunological modeling immensely. Many immune
cell types are involved in responses, and restricting a model to a single type severely limits
its applicability. Therefore, model-building should be a dialog between the modeler and
the disciplinary scientist. I have used the published results of immunologists to construct
a model, and I hope that immunologists will be able to use this model to guide future
experiments.
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Calibrating the distance metrics §
There are three versions of the CTL model, each using a different deﬁnition of string
distance: Hamming, xor, and modiﬁed Manhattan. This appendix deﬁnes these metrics
and summarizes their calibration in the context of the model using the procedure described
in Section 4.2. Each of the following three sections consists of six parts:
1. A formal deﬁnition of one of the distance metrics.
2. The alphabet size and string lengths for the peptides and TCRs. The alphabet size
and string lengths must be determined for the receptors and ligands in the CTL
model. One constraint is that the ratio of the length of a TCR’s MHC-binding por-
tion to its peptide-binding portion must be 2:3 (Detours et al., 1999). Another con-
straint is that the number of possible TCR strings that the model can create should
be at least 1015, which is the estimated number of different TCRs that a human
can generate (Davis and Bjorkman, 1988). The number of possible TCR strings for
strings of length L using an alphabet of size k is kL.
3. The thymic selection thresholds. Using the deﬁnition of the metric, the string
lengths, and the alphabet size, I apply the algorithm described in Detours et al.
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(1999) to ﬁnd the distance distribution of random pre-selection TCRs from their
selecting peptides. This distribution is used to compute the positive and negative
thymic selection thresholds according to the procedure described in Section 4.2.1.
The positive and negative selection thresholds are found to satisfy observed con-
straints of thymic selection in murine systems.
4. The size of the pre-selection and na¨ ıve repertoires and the average number of re-
sponding clones per epitope. Because the CTL model is calibrated using data from
mouse experiments, mouse estimates are used to determine the size of the na¨ ıve
repertoire and the number of na¨ ıve clones per epitope in the model. 106 −107 is
the estimated number of clones in a mouse’s na¨ ıve repertoire (Pannetier et al., 1993;
Casrouge et al., 2000), and the number of responding na¨ ıve clones per epitope has
been estimated to be 10–20 in mice (Blattman et al., 2002). Both of these values
depend on the size of the pre-selection repertoire. The number of clones in the
na¨ ıve repertoire size is the number in the pre-selection repertoire times the fraction
of clones that survive selection (computed in part 3). The foreign peptide response
frequency, which is the fraction of na¨ ıve clones that respond to a random peptide
presented on self MHC, is computed using a procedure from Detours et al. (1999).
The average number of clones that respond to an epitope is the foreign peptide re-
sponse frequency, which has been experimentally observed to be between 10−6 and
10−4 (Stockinger et al., 1980; Zinkernagel, 1996), multiplied by the na¨ ıve repertoire
size.
5. The distribution of distances between two random strings. This distribution is used
by the lazy evaluation procedure described in Section 4.2.2. To lazily generate
the CTLs for each MHC–epitope complex, the simulation generates the appropri-
ate number of pre-selection TCRs that are at each distance from 0 to one less than
the cross-reactive cutoff. To do this, I ﬁrst determine the distribution of distances
from random strings to a reference string. This distribution gives the proportion of
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pre-selection TCRs that are at each distance from the MHC–epitope complex. One
can compute the expected number of clones at each distance by multiplying this
distribution by the total number of clones in the full pre-selection repertoire, which
is about 108. During a simulation, to compute the actual number of clones at each
distance d, a random number is drawn from the binomial distribution, using the size
of the full pre-selection repertoire and the proportion of clones at d as parameters.
6. An algorithm for generating a random string at the desired distance from a given
string. After the number of strings to generate at distance d from an MHC–epitope
complex string is determined, the TCR strings are generated. These new strings
form the pre-selection repertoire for a particular MHC–epitope pair.
In the sections that follow, I use the following notation: strings are sequences of L
digits, digits are drawn from an alphabet of size k, U is the universe of possible strings,
|U| is the number of different strings in U, I(x,y) is the distance between two digits x and
y, D(a,b) is the distance between two strings a and b, and Pr{X =z} is the probability that
random variable X is equal to z.
A.1 Calibrating Hamming distance
1. A formal deﬁnition of Hamming distance. The Hamming distance between two
strings is the number of positions in which they differ (Hamming, 1950). The Ham-
ming distance IH between two digits x and y is:
IH(x,y) =



1 if x = y
0 if x  = y
(A.1)
The Hamming distance DH between two strings a and b is
DH(a,b) =å
i
IH(ai,bi) (A.2)
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where ai and bi are the ith digits of the strings a and b.
2. The alphabet size and string lengths for the peptides and TCRs. Hamming distance
is “coarse” because the distance between two digits is a boolean, rather than scalar,
value (Equation A.1). The distance between two strings can only take values be-
tween 0 and L, the length of the strings. If one chose to use small string lengths to
represent the peptide and MHC strings (such as 6 digits and 4 digits as suggested
in Detours et al. (1999)), it would be difﬁcult to ﬁnd positive and negative selection
thresholdssuchthat1%–3%ofpre-selectionclonessurvivethymicselection. There-
fore, the string lengths must be longer. Long strings L can lead to an unreasonably
large universe of TCRs, which is kL where k is the alphabet size. Therefore, I chose
a small alphabet size to reduce the number of possible TCRs. For reasons discussed
in Kanerva (1988) and Smith et al. (1997), 2 might not be a suitable alphabet size, so
I set the alphabet size to be 3. I test many combinations of MHC length and peptide
length such that their ratio is 4:6 to match the values in Detours et al. (1999).
3. The thymic selection thresholds. The distribution of distances between a TCR and
its selecting MHC–self peptide complex can be derived using Equation A.2 and the
procedure in Detours et al. (1999). I used this distribution to ﬁnd string lengths
for the MHC- and peptide-binding portions of the TCR that satisfy the 2:3 length
ratio, contain an appropriate-sized selection window of about 1–3% of pre-selection
TCRs, and are of moderate length. I found that an MHC length of 32 and a peptide
length of 48 yielded several appropriately sized selection windows; the distances of
34, 35, or 36 would all be plausible thymic selection windows (Figure A.1). For all
of these candidate windows, the positive and negative selection thresholds are equal,
so only TCRs that are exactly 34, 35, or 36 away from the nearest MHC–self peptide
complex survive thymic selection. I chose to set the positive and negative selection
thresholds to clones at distance 34 for the Hamming distance version of the model.
About 3.96% of clones survive thymic selection.
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Figure A.1: Setting the thymic selection window using Hamming distance. The thymic
selection window should coverabout 1-3% ofthe possible strings, so the strings atdistance
34, 35, or36 satisfythis constraint (indicated by the arrows). About1–2 times more strings
should be of higher afﬁnity than those in the window, so the cumulative distribution (in
this case, the sum of the number of strings up to but not including the current distance)
should be about 1–2 times larger than the number of strings in the selection window. The
strings at distance 34, 35, or 36 each satisfy this constraint.
4. The size of the pre-selection and na¨ ıve repertoires and the average number of re-
sponding clones per epitope. When the size of the pre-selection repertoire is set to
8×107 clones, the na¨ ıve repertoire size is 3.17×106, which agrees with observa-
tions in mice. The expected number of responding clones per epitope is simply the
na¨ ıve repertoire size multiplied by the foreign peptide response frequency. I calcu-
lated the foreign peptide response frequency to be 8.40×10−6, which falls within
the range observed in laboratory experiments. Using these values, the number of
responding clones per epitope is about 27.
5. The distribution of distances between two random strings. The lazy evaluation al-
gorithm requires that the expected number of strings that are a given distance away
from a reference string be computed. In Kanerva (1988), it was proven that the pro-
portion of all strings that are distance d away from a reference string is deﬁned by
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the binomial:
Pr{DH(x,y) = d} = B(L,
k−1
k
,d) (A.3)
=
 
L
d
  
k−1
k
 d 
1−
k−1
k
 L−d
(A.4)
where Pr{DH(x,y) = d} is the probability that random strings x and y are exactly
Hamming distance d apart, k is the alphabet size, and L is the length of the string.
6. An algorithm for generating a random string at the desired distance from a given
string. I generate random strings at Hamming distance d from a reference string by
randomly choosing d digits to differ from the reference string. These digits are set
to random digits that are not equal to the other string’s, while the remaining digits
are copied from the reference string.
A.2 Calibrating xor distance
1. A formal deﬁnition of xor distance. The xor distance, Dxor, is the sum of the bitwise
xors between the corresponding digits of two strings (Detours et al., 1999). For two
one-bit numbers, the xor operation (⊕) is deﬁned to be 1 if the numbers are different
and 0 if they are the same. This operation is extended to multi-bit numbers by
decomposing each number x into a sum of bits x0...xi, each multiplied by 2 raised
to a power: x = åixi2i. The xor distance between two digits, Ixor, is:
Ixor(x,y) = x⊕y (A.5)
= å
i
(xi⊕yi)2i (A.6)
where xi and yi are the ith bits of the digits x and y. The xor distance Dxor between
two strings is
Dxor(a,b) =å
i
Ixor(ai,bi) (A.7)
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where ai and bi are the ith digits of the strings a and b. For example, the
xor distance between 3 and 5 is 6 because 3 can be decomposed into the sum
0×22+1×21+1×20 and 5 is 1×22+0×21+1×20, and the sum of the xors of
the coefﬁcients of the powers of 2 is 1×22+1×21+0×20, which is 6:
3=0×22+1×21+1×20
+ 5=1×22+0×21+1×20
6=1×22+1×21+0×20
2. The alphabet size and string lengths for the peptides and TCRs. I use values derived
in Detours et al. (1999) for the lengths of the MHC and peptide strings: 4 digits for
the MHC strings and 6 for the peptides. However, I reduced the alphabet size from
256 to 128 for computational efﬁciency and to reduce the size of the universe of
possible TCRs from 1.2×1024 to 1.2×1021.
3. The thymic selection thresholds. The expected distribution of distances from a ran-
dom TCR to its selecting MHC–self peptide complex is plotted in Figure A.2. This
distribution was veriﬁed by generating 3 random MHC strings and 30,000 random
self peptide strings then computing the distance between 100,000 random TCR
strings and the nearest MHC–self peptide complex string. The expected and ob-
served distributions agree except in the low-afﬁnity (large distance) tail, which are
eliminated by positive selection (Figure A.2). The thymic selection window consists
of strings at distances from 140 to 149 from the selecting MHC–self peptide com-
plex. This range covers 0.807% of the random TCR strings, and 61% of the TCRs
that survive positive selection are killed by negative selection.
4. The size of the pre-selection and na¨ ıve repertoires and the average number of re-
sponding clones per epitope. I set the size of the pre-selection repertoire to 2.5×108
clones, and after thymic selection the repertoire is reduced to 2×106. The foreign
peptide response frequency is 1.27×10−5, so about 25 na¨ ıve clones respond to each
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epitope. Note that the number of pre-selection clones is higher than that used in
the Hamming version (Section A.1) because a smaller fraction of clones happens to
survive selection in the xor version.
Figure A.2: The distribution of xor distances between a pre-selection TCR and the nearest
MHC–self complex. The negative selection threshold is 140 and the positive is 149 (indi-
cated on the x axis by the “-” and “+”). This results in a window size containing 0.807% of
all possible TCRs, with about 1.29% of pre-selection clones eliminated by negative selec-
tion. Theplotshowstheexpectedresults(◦)andempiricalresultsfromgenerating100,000
random TCR strings (solid line). The computations were performed using 3 MHC types,
10000 self peptides per MHC type, MHC length of 4 digits, peptide length of 6 digits, and
an alphabet size of 128.
5. The distribution of distances between two random strings. For the lazy evaluation
algorithm, I compute the distribution of distances between two random strings. The
distance between two random strings is the sum of the distances between their corre-
sponding digits, and the distribution of the sum of independent random variables is
the convolution of their individual distributions. The probability distribution of dis-
tances between two random digits, Pr{Ixor(x,y) = d}, is uniform for d = 0...k−1
(where k is the alphabet size) and zero elsewhere. Therefore, the probability distri-
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Figure A.3: The probability distribution of xor distances between two random strings of
length 10 using an alphabet size of 128.
bution of xor distances between two strings is:
Pr{Dxor(a,b) = d} = Pr{Ixor}n (A.8)
where Pr{Ixor}n is the probability distribution Pr{Ixor} convolved with itself n−1
times. An example of this distribution using the string parameters used by the CTL
model (string length of 10 and alphabet size of 128) is plotted in Figure A.3.
6. An algorithm for generating a random string at the desired distance from a given
string. To generate strings at a given distance from a reference string, I use the bit
composition sets algorithm, described in Detours et al. (2001). This technique is
computationally efﬁcient but requires a large amount of memory.
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A.3 Calibrating a modiﬁed Manhattan distance
1. A formal deﬁnition of modiﬁed Manhattan distance (L′
1). I use a modiﬁed version of
the ﬁrst-order Minkowski metric, L1. The standard ﬁrst-order Minkowski distance
is the sum of the absolute values of the differences between the digits of two strings:
DL1(a,b) =å
i
|ai−bi| (A.9)
In two dimensions, it can represent the number of blocks one needs to travel to
go between two points in a city if one must travel along a grid of streets. There-
fore, L1 is also known as Manhattan distance, city-block distance, and taxicab dis-
tance (Krause, 1987).
I use a modiﬁed Manhattan metric, which I denote L′
1, in which the dimensions
have cyclic boundaries so that the space “wraps around” (Figure A.4). The distance
between two digits is:
IL1′(x,y) =



|x−y| if |x−y| ≤ k/2
k−|x−y| otherwise
(A.10)
The distance between two strings is the sum of the distances between their corre-
sponding digits:
DL1′(a,b) =å
i
IL1′(ai,bi) (A.11)
In standard L1 space, the positions near the edges of the space have truncated neigh-
borhoods. The term neighborhood is the set of strings that are at or within a given
distance of a reference string. For example, on a line, a point at position 2 has two
neighbors that are distance 1 away (at 1 and 3), while a point at 0 has only one neigh-
bor that is distance 1 away (at 1). Using L′
1 space with cyclic boundaries, the point
at 0 has two neighbors at distance 1: the points at 1 and n, where n is the maximum
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Figure A.4: The modiﬁed Manhattan distance (L′
1) in 2 dimensions. It is the same as the
standard L1 distance except that boundaries are cyclic so the space “wraps around.” In this
ﬁgure, all o’s are distance 2 away from the x.
value on the line. Thus, the neighborhoods of all points in L′
1 have the same size and
shape.
2. The alphabet size and string lengths for the peptides and TCRs. For the modi-
ﬁed Manhattan distance L′
1, I use the lengths of the MHC and peptide strings from
Detours et al. (1999): 4 digits for the MHC strings and 6 for the peptides. I chose
an alphabet of size 32, so the number of possible TCRs is 3210 = 1.13×1015.
3. The thymic selection thresholds. Using the derivation from Detours et al. (1999), I
found that the thymic selection window consists of the clones at distance 19 from
their selecting peptides, resulting in 0.778% of the pre-selection repertoire surviv-
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ing thymic selection (Figure A.5). About 70% of the clones that survive positive
selection are killed by negative selection.
4. The size of the pre-selection and na¨ ıve repertoires and the average number of re-
sponding clones per epitope. I set the size of the pre-selection repertoire to 2.5×108
clones, and after thymic selection the repertoire is reduced to 2×106. The foreign
peptide response frequency is 1.43×10−5, resulting in about 28 responding clones
per epitope.
Figure A.5: The distribution of modiﬁed Manhattan distances between a random pre-
selection TCR and the nearest MHC–self complex. The thymic selection window consists
of clones at distance 19. This results in a window size of 0.778%, with about 1.78% of
pre-selection clones eliminated by negative selection. The expected distribution is denoted
by ◦ and a trial using 100,000 random TCR strings by the solid line. The computations
were performed using 3 MHC types, 10000 self peptides per MHC, MHC length of 4
digits, peptide length of 6 digits, and an alphabet size of 32.
5. The distribution of distances between two random strings. As was the case for xor
distance (Section A.2), the distribution of distances between two random strings is
the convolution of the distribution of distances between two random digits. The
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Figure A.6: The probability distribution of modiﬁed Manhattan distances (L′
1) between
two random strings of length 10 using an alphabet size of 32.
probability distribution of inter-digit distances for L′
1 is:
Pr{IL1′(x,y) = d} =

   
   
1/k if d = 0 or d = k/2
2/k if d < k/2
0 otherwise
(A.12)
where k is the alphabet size. Note that d can only equal k/2 when k is even. The
distribution of inter-string distances is Pr{IL′
1}L. An example of this distribution
using the values used by the model (string length of 10 and alphabet size of 32) is
plotted in Figure A.6.
6. An algorithm for generating a random string at the desired distance from a given
string. I have implemented an algorithm to generate random strings at a given L′
1
distance from a reference string. One part of this algorithm calculates probability
distributions required to generate these strings. The recursive routine takes two pa-
rameters, n and d, which are the length of the string and the desired distance from
the reference string. For all valid combinations of n and d, the routine computes and
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stores the probability distribution of distances for the ﬁrst digit of the string. For ex-
ample, if half of all possible strings of length n and distance d from the origin begin
with the digits 1 or k−1 (both distance 1 from the origin), then the distribution of
distances for the ﬁrst digit would be 0.5 for distance 1. For a string of length 1 (i.e.,
n = 1), the distribution that describes the number of strings whose ﬁrst (and only)
digit is distance d from the origin is:
|U|Pr{IL1′(a1,b1) = r} =

     
     
1 if d = 0 and r = 0 or
if d = k/2 and r = k/2
2 if d < k/2 and r = d
0 otherwise
(A.13)
From this distribution, the distributions for strings of length d can be computed
recursively:
|U|Pr{IL1′(ad,bd) = r} =

   
   
|U|Pr{IL1′(ad−1,bd−1) = d−r} if r = 0 or
if r = k/2
2|U|Pr{IL1′(ad−1,bd−1) = d−r} otherwise
(A.14)
The digit distributions are normalized to sum to 1 to obtain probability distributions.
The digit distance distribution is used to generate new random strings at distance d
from a reference string. The ﬁrst digit is chosen by randomly drawing a digit dis-
tance d1 from the distribution Pr{IL1′(aL,bL) = r}. This random value is converted
to a digit by either adding or subtracting (with equal probability) it from the digit
in the reference string. The distance d2 for the second digit is drawn from the dis-
tribution Pr{IL1′(aL−1,bL−1) = d −d1}. Again, this distance is either added to or
subtracted from the second digit in the reference string. This procedure is repeated
to compute the remaining digits of the new string.
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Alternative biological assumptions §
The model presented in this work is not intended to be comprehensive. My intent was
to create a computationally efﬁcient model of the CTL response to infection that would
elucidate issues of repertoire selection and the dynamics of the response. If one is inter-
ested in other aspects of CTLs, the model would need to be extended. In addition, some
features of the T cell response are incompletely or possibly incorrectly understood, so I
often had to choose among competing hypotheses. The purpose of this appendix is to list
a few alternatives to the assumptions used by my CTL model.
In Section 3.2.2, the representation of afﬁnity in the model has been simpliﬁed to
exclude the phenomenon of serial triggering, in which a single MHC–peptide complex
can stimulate multiple TCRs (Valitutti et al., 1995). An MHC–peptide complex that has a
low dissociation rate with a CTL’s TCRS stimulates only a small number of TCRs because
each binding interaction takes a long time. A complex with a higher dissociation rate
would have the opportunity to bind to more TCRs per unit time because after disengaging
with one TCR it could bind to another. Thus both the afﬁnity of the interactions and
the dissociation rate determine the stimulation that a CTL receives. The model could be
extended by adding dissociation rates to the CTL recruitment process.
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In the same section, I assert that memory cells have the same antigenic stimulation re-
quirements as na¨ ıve cells (Bachmann et al., 1999) and incorporate this fact into the model.
Some studies have found that memory cells are more sensitive to antigen (Pihlgren et al.,
1996). However, this effect is not consistently supported in the literature, and it is certainly
not well quantiﬁed. Memory cells in the model can respond to lower levels of antigen
without requiring lower stimulation thresholds because they are usually present in larger
numbers than na¨ ıve cells and require less time to begin their initial rounds of proliferation.
Simultaneous responses to different epitopes expressed by the same infected cells are
independent in the model (Section 3.2.3). This effect makes the modeling much easier and
less computationally expensive, but it cannot be true. There must be competition for non-
speciﬁc resources such as cytokines (Borghans et al., 1999) or even the surface of infected
cells. However, it is not known how signiﬁcant this competition is during the course of a
typical response.
The model assumes that newly recruited effector cells have a constant death rate and
divide for a ﬁxed number of cycles before they stop replicating (Section 3.2.4), but the
results from the CTL model described in Allan et al. (2004) indicate that the death rate
for an effector cell should increase and the proliferation rate should decrease with each
division. This is probably true, but current CFSE technology is not accurate enough to
estimate the death and replication rates during the entire course of a response, so I have
used the simpler assumption that these rates are constant.
The model uses a considerably simpliﬁed CTL life cycle (Section 3.2). CTLs perform
many roles during an immune response, such as eliminating infected cells and producing
cytokines, and the magnitude of infection might determine how many of these functions
they adopt (Auphan-Anezin et al., 2003). These functions can also become progressively
downregulated at the end of a response or during a chronic response (Fuller and Zajac,
2003; Wherry et al., 2003), as mentioned in Section 6.1. My model assumes an “all-or-
nothing” activation of CTLs, while a more comprehensive model would allow for partial
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activation.
All effector cells in the model have an equal probability of converting to memory
throughout the course of the response (Section 3.2.5), but this assumption does not agree
with recent ﬁndings that suggest that some effector cells are pre-determined to become
memory cells. Some studies show that the subset of effectors that express the interleukin 7
receptor a-chain (IL-7Ra) early in the response become memory cells (Kaech et al., 2003;
Huster et al., 2004). Expression of CD8aa receptors by effectors has also been found to
correlate with conversion to memory (Madakamutil et al., 2004). However, it is not known
if the effector cells that express IL-7Ra or CD8aa behave differently during the response
than those that don’t, so making this distinction in the model would not affect its behavior
without this additional information.
Proliferation rates for na¨ ıve- and memory-derived (primary and secondary) effectors
are the same in the model (Section 3.2.5), but in reality secondary effectors might have
shorter division times (Rogers et al., 2000). Net population growth of secondary effectors
happens to be higher in the model because they have lower death rates than primary effec-
tors. Shorter division times would increase the secondary effector cell population growth
even further.
The timing of the expression of epitopes probably plays a major role in im-
munodominance (van der Most et al., 2003). For example, CTLs responding to the
LCMV epitopes expressed signiﬁcantly earlier than others could dominate the re-
sponse (Fuller-Pace and Southern, 1988). The CTL model does not consider timing ef-
fects, and all epitopes are immediately expressed upon the infection of healthy cells (Sec-
tion 3.2.2). Only the expression levels of different epitopes differ in the model.
The model of thymic selection described in Section 4.2.1 makes many simplify-
ing assumptions based on those used in Detours et al. (1999). Since that paper’s pub-
lication, a handful of other thymic selection models have appeared in the literature.
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van Den Berg et al. (2001) introduces antigen-presenting cells (APCs) that express a mul-
titude of self peptides in the thymus. It also uses a more complex representation of
CTL stimulation than that used in Detours et al. (1999). These features allow different
self peptides to be presented at different levels, which could affect the na¨ ıve CTL reper-
toire (Laurie et al., 2004). The model in Faro et al. (2004) divides the thymus into two
compartments: the cortex and the medulla. This division adds a new level of detail that
could potentially be calibrated with experimental data. Another feature that could Finally,
CTLs can modulate the number of TCRs they express in response to the environment
in the thymus and the periphery (Grossman and Paul, 2001; Anderton and Wraith, 2002).
This fact complicates the distinction between autoreactive and non-autoreactive CTLs, and
models (such as van Den Berg and Rand (2004)) have been used to study these effects.
I assume that the cross-reactive cutoff is equal to the negative selection threshold used
in thymic selection (Section 4.2.2), even though the the cross-reactive cutoff might be
more stringent (Pircher et al., 1991). This would imply that a pre-selection cell is more
sensitive to peptides and would respond to a larger range of peptides than a post-selection
effector cell. Adding this effect to the model might affect a CTL model of autoimmunity, a
phenomenon I do not address—uninfected cells in the model do not express self epitopes.
Finally, most of the data used in the model are based on murine experiments. Many
modiﬁcations would be required to convert the model to accommodate human data. One
could simply multiply many of the constants by 10,000 to represent the difference in mass
between mice and humans, but one should probably use more realistic scaling laws, such
as those described in Wiegel and Perelson (2004), to adapt the model to other organisms.
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afﬁnity • The strength of the binding interaction between a single TCR and an MHC–
peptide complex
anergy • A state of unresponsiveness in immune system cells.
antigen • An agent that stimulates an immune response, such as a virus or bacteria.
avidity • The total strength of the binding interactions between a CTL’s TCRs and the
MHC–peptide complexes expressed by a single target cell.
clone • A group of genetically identical cells derived from the same ancestor.
cross-reactivity • The ability of a single lymphocyte to respond to both an epitope and its
variants.
cross-reactive cutoff • The maximum antigenic distance between a TCR’s cognate pep-
tide and another peptide recognized by the same TCR.
CTL • Cytotoxic T lypmohcyte. An immune cell that can eliminate infected cells by
detecting abnormal peptides presented by MHC.
degeneracy • Peptide binding degeneracy is proportional to the size of the set of peptides
to which a TCR can bind. Thus, a TCR that can bind to a large set of peptides has a high
peptide-binding degeneracy.
effector T cell • A replicating T cell that eliminates infected cells.
epitope • The portion of an antigen that triggers an immune response. In the case of CTLs,
a foreign peptide generated by virus or bacteria and presented by MHC.
foreign peptide response frequency • The fraction of clones that respond to a particular
foreign peptide presented by MHC.
LCMV • Lymphocytic choriomeningitis virus. A non-cytopathic virus that infects mice.
LCMV is often used to study the murine T cell response.
memory T cell • A quiescent T cell derived from an effector cell. These long-lived cells
are created during T cell response and respond to antigen more quickly than na¨ ıve cells.
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MHC • Major histocompatibility complex. MHC molecules present fragments of a cell’s
internal proteins on the cell’s surface.
na¨ ıve T cell • A T cell that has survived thymic selection but has not yet been exposed to
antigen.
negative selection • The phase of thymic selection that follows positive selection. Nega-
tive selection eliminates T cells that have high afﬁnity for one or more MHC–self peptide
complexes.
peptide • A short sequence of amino acids, a protein fragment.
positive selection • Positive selection eliminates T cells that have low afﬁnity for all
MHC–self peptide complexes expressed in the thymus.
programmed response • The pre-determined sequence of actions that a na¨ ıve T cell takes
after antigenic stimulation. Even a brief exposure to antigen can cause a T cell to go
through many rounds of division, adopt effector functions, then convert to memory cells.
repertoire • A set of T cells.
selecting peptide • During thymic selection, a CTL’s selecting peptide is the MHC–self
peptide complex to which the CTL has the highest afﬁnity.
string distance metric • A function that takes two strings as input and returns a scalar
value. The triangle inequality holds, so the distance between two strings A and B is less
than or equal to the sum of the distances between A and a third string, C, and between B
and C.
T cell • A type of lymphocyte.
TCR • T cell receptor. A CTL has many TCRs on its surface that bind to MHC–peptide
complexes on other cells.
thymic selection • A process that takes place during the maturation of CTL precursors.
CTLs that survive positive and negative selection exit the thymus and mature to become
na¨ ıve cells.
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